Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	cysteine-type deubiquitinase activity	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP8 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP33 USP17L8 USP17L13	4.46e-24	114	167	22	GO:0004843
GeneOntologyMolecularFunction	deubiquitinase activity	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP8 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP33 USP17L8 USP17L13	3.19e-23	124	167	22	GO:0101005
GeneOntologyMolecularFunction	ubiquitin-like protein peptidase activity	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP8 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP33 USP17L8 USP17L13	3.19e-22	137	167	22	GO:0019783
GeneOntologyMolecularFunction	cysteine-type peptidase activity	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP8 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP33 USP17L8 USP17L13	6.18e-19	192	167	22	GO:0008234
GeneOntologyMolecularFunction	peptidase activity	USP17L7 HGFAC USP17L21 TMPRSS9 USP17L4 OVCH2 USP17L2 USP17L12 USP17L1 ADAMTS3 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP8 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP33 USP17L8 USP17L13	3.91e-11	654	167	26	GO:0008233
GeneOntologyMolecularFunction	inhibitory MHC class I receptor activity	LILRA1 LILRA3 LILRA2 LILRA4	2.22e-06	12	167	4	GO:0032396
GeneOntologyMolecularFunction	MHC class I protein binding	LILRA1 LILRA2 HLA-E HLA-F HLA-G	6.46e-06	32	167	5	GO:0042288
GeneOntologyMolecularFunction	MHC protein binding	LILRA1 LILRA2 HLA-E HLA-F HLA-G TRGV3	8.83e-06	58	167	6	GO:0042287
GeneOntologyMolecularFunction	MHC class I receptor activity	LILRA1 LILRA3 LILRA2 LILRA4	1.32e-05	18	167	4	GO:0032393
GeneOntologyMolecularFunction	intracellularly cGMP-activated cation channel activity	CNGB3 CNGB1 CNGA4	1.96e-05	7	167	3	GO:0005223
GeneOntologyMolecularFunction	CD8 receptor binding	HLA-E HLA-F HLA-G	4.65e-05	9	167	3	GO:0042610
GeneOntologyMolecularFunction	TAP complex binding	HLA-E HLA-F HLA-G	4.65e-05	9	167	3	GO:0062061
GeneOntologyMolecularFunction	intracellularly cAMP-activated cation channel activity	CNGB3 CNGB1 CNGA4	6.60e-05	10	167	3	GO:0005222
GeneOntologyMolecularFunction	TAP1 binding	HLA-E HLA-F HLA-G	6.60e-05	10	167	3	GO:0046978
GeneOntologyMolecularFunction	TAP2 binding	HLA-E HLA-F HLA-G	6.60e-05	10	167	3	GO:0046979
GeneOntologyMolecularFunction	TAP binding	HLA-E HLA-F HLA-G	6.60e-05	10	167	3	GO:0046977
GeneOntologyMolecularFunction	IgM binding	LILRA1 LILRA2 LILRA4	9.02e-05	11	167	3	GO:0001791
GeneOntologyMolecularFunction	beta-2-microglobulin binding	HLA-E HLA-F HLA-G	1.20e-04	12	167	3	GO:0030881
GeneOntologyMolecularFunction	intracellularly cyclic nucleotide-activated monoatomic cation channel activity	CNGB3 CNGB1 CNGA4	1.55e-04	13	167	3	GO:0005221
GeneOntologyMolecularFunction	cyclic nucleotide-activated monoatomic ion channel activity	CNGB3 CNGB1 CNGA4	1.55e-04	13	167	3	GO:0043855
GeneOntologyMolecularFunction	intracellularly ligand-gated monoatomic ion channel activity	RYR2 CNGB3 CNGB1 CNGA4	1.60e-04	33	167	4	GO:0005217
GeneOntologyMolecularFunction	cGMP binding	CNGB3 CNGB1 CNGA4	2.97e-04	16	167	3	GO:0030553
GeneOntologyMolecularFunction	natural killer cell lectin-like receptor binding	HLA-E HLA-F HLA-G	3.58e-04	17	167	3	GO:0046703
GeneOntologyMolecularFunction	T cell receptor binding	HLA-E HLA-F HLA-G	5.90e-04	20	167	3	GO:0042608
GeneOntologyMolecularFunction	HLA-A specific inhibitory MHC class I receptor activity	LILRA1 LILRA2	6.84e-04	5	167	2	GO:0030107
GeneOntologyMolecularFunction	peptide antigen binding	HLA-E HLA-F HLA-G TRGV3	7.46e-04	49	167	4	GO:0042605
GeneOntologyMolecularFunction	HLA-B specific inhibitory MHC class I receptor activity	LILRA1 LILRA2	1.02e-03	6	167	2	GO:0030109
GeneOntologyMolecularFunction	MHC class Ib protein complex binding	LILRA1 LILRA2	1.42e-03	7	167	2	GO:0023025
GeneOntologyMolecularFunction	channel activity	BEST1 AQP12A PANX2 AQP12B RYR2 CNGB3 OTOP1 ANO7 CACNG4 FXYD3 CNGB1 CNGA4	1.59e-03	525	167	12	GO:0015267
GeneOntologyMolecularFunction	passive transmembrane transporter activity	BEST1 AQP12A PANX2 AQP12B RYR2 CNGB3 OTOP1 ANO7 CACNG4 FXYD3 CNGB1 CNGA4	1.61e-03	526	167	12	GO:0022803
GeneOntologyMolecularFunction	ABC-type glutathione S-conjugate transporter activity	ABCC11 ABCC2	1.88e-03	8	167	2	GO:0015431
GeneOntologyMolecularFunction	ATPase-coupled transmembrane transporter activity	IPO8 ABCC11 BCS1L ABCA7 ABCC2	2.24e-03	109	167	5	GO:0042626
GeneOntologyMolecularFunction	immune receptor activity	MPL IL10RA LILRA1 LILRA3 LILRA2 LILRA4	2.68e-03	165	167	6	GO:0140375
GeneOntologyBiologicalProcess	protein deubiquitination	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP8 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP33 USP17L8 USP17L13	4.29e-23	125	173	22	GO:0016579
GeneOntologyBiologicalProcess	protein modification by small protein removal	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP8 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP33 USP17L8 USP17L13	1.11e-21	144	173	22	GO:0070646
GeneOntologyBiologicalProcess	protein modification by small protein conjugation or removal	USP17L7 TRAF7 USP17L21 USP17L4 USP17L2 HDAC4 USP17L12 USP17L1 USP17L20 USP17L11 MARCHF2 USP17L24 USP17L5 G2E3 USP17L10 USP17L19 TTC3 USP17L18 USP8 PLAA USP17L17 FBXW5 USP17L6P USP17L3 DCAF11 USP17L22 USP17L15 USP33 USP17L8 USP17L13	1.38e-09	1009	173	30	GO:0070647
GeneOntologyBiologicalProcess	post-translational protein modification	USP17L7 TRAF7 USP17L21 USP17L4 USP17L2 HDAC4 USP17L12 USP17L1 USP17L20 USP17L11 MARCHF2 USP17L24 USP17L5 G2E3 USP17L10 USP17L19 TTC3 USP17L18 USP8 PLAA USP17L17 FBXW5 USP17L6P USP17L3 DCAF11 USP17L22 USP17L15 USP33 USP17L8 USP17L13	5.85e-09	1074	173	30	GO:0043687
GeneOntologyBiologicalProcess	interleukin-10-mediated signaling pathway	IL10RA LILRA1 LILRA3 LILRA2	1.51e-06	11	173	4	GO:0140105
GeneOntologyBiologicalProcess	antigen processing and presentation of endogenous peptide antigen via MHC class Ib via ER pathway	HLA-E HLA-F HLA-G	2.31e-06	4	173	3	GO:0002488
GeneOntologyBiologicalProcess	antigen processing and presentation of endogenous peptide antigen via MHC class Ib via ER pathway, TAP-dependent	HLA-E HLA-F HLA-G	2.31e-06	4	173	3	GO:0002489
GeneOntologyBiologicalProcess	antigen processing and presentation of exogenous protein antigen via MHC class Ib, TAP-dependent	HLA-E HLA-F HLA-G	5.73e-06	5	173	3	GO:0002481
GeneOntologyBiologicalProcess	antigen processing and presentation of exogenous peptide antigen via MHC class Ib	HLA-E HLA-F HLA-G	5.73e-06	5	173	3	GO:0002477
GeneOntologyBiologicalProcess	antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-dependent	HLA-E HLA-F HLA-G	3.15e-05	8	173	3	GO:0002485
GeneOntologyBiologicalProcess	cellular response to type II interferon	EPRS1 HLA-E HLA-F HLA-G IRF1 DAPK1 OTOP1	5.01e-05	114	173	7	GO:0071346
GeneOntologyBiologicalProcess	regulation of CD8-positive, alpha-beta T cell proliferation	HLA-E IRF1 SLC4A2	6.66e-05	10	173	3	GO:2000564
GeneOntologyBiologicalProcess	positive regulation of natural killer cell cytokine production	HLA-E HLA-F HLA-G	9.11e-05	11	173	3	GO:0002729
GeneOntologyBiologicalProcess	CD8-positive, alpha-beta T cell proliferation	HLA-E IRF1 SLC4A2	9.11e-05	11	173	3	GO:0035740
GeneOntologyBiologicalProcess	natural killer cell cytokine production	HLA-E HLA-F HLA-G	1.21e-04	12	173	3	GO:0002370
GeneOntologyBiologicalProcess	regulation of natural killer cell cytokine production	HLA-E HLA-F HLA-G	1.21e-04	12	173	3	GO:0002727
GeneOntologyBiologicalProcess	cellular response to cytokine stimulus	MPL IL10RA TRAF7 EPRS1 LRAT LILRA1 LILRA3 LILRA2 SMARCA5 HDAC4 HLA-E HLA-F HLA-G IRF1 DAPK1 JARID2 OTOP1 ROBO1 OCSTAMP LILRA4	1.83e-04	967	173	20	GO:0071345
GeneOntologyBiologicalProcess	response to type II interferon	EPRS1 HLA-E HLA-F HLA-G IRF1 DAPK1 OTOP1	1.90e-04	141	173	7	GO:0034341
GeneOntologyBiologicalProcess	adaptive immune response	MPL LILRA1 LILRA3 LILRA2 HLA-E HLA-F TRGV2 HLA-G TRGV3 TRGV4 TRGV5 IRF1 TRBV14 TRBV7-7 TRBV7-4 TRBV7-3 TRBV7-2 SLA2	2.48e-04	838	173	18	GO:0002250
GeneOntologyBiologicalProcess	negative regulation of leukocyte differentiation	LILRA1 LILRA2 HLA-G IRF1 SLC4A2 LRRC17 LILRA4	2.90e-04	151	173	7	GO:1902106
GeneOntologyBiologicalProcess	antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-independent	HLA-E HLA-F HLA-G	3.00e-04	16	173	3	GO:0002486
GeneOntologyBiologicalProcess	antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway	HLA-E HLA-F HLA-G	3.62e-04	17	173	3	GO:0002484
GeneOntologyBiologicalProcess	antigen processing and presentation of endogenous peptide antigen via MHC class Ib	HLA-E HLA-F HLA-G	3.62e-04	17	173	3	GO:0002476
GeneOntologyBiologicalProcess	negative regulation of hemopoiesis	LILRA1 LILRA2 HLA-G IRF1 SLC4A2 LRRC17 LILRA4	3.96e-04	159	173	7	GO:1903707
GeneOntologyBiologicalProcess	antigen processing and presentation of peptide antigen via MHC class Ib	HLA-E HLA-F HLA-G	4.31e-04	18	173	3	GO:0002428
GeneOntologyBiologicalProcess	antigen processing and presentation of exogenous peptide antigen via MHC class I	HLA-E HLA-F HLA-G	4.31e-04	18	173	3	GO:0042590
GeneOntologyCellularComponent	endoplasmic reticulum membrane	USP17L7 LRAT USP17L21 USP17L4 USP17L2 APOO USP17L12 USP17L1 USP17L20 USP17L11 MARCHF2 SRD5A1 HLA-E HLA-F HLA-G USP17L5 TMTC2 MGLL CYP4F2 USP17L10 USP17L19 PNLDC1 PANX2 GBA2 RYR2 USP17L18 USP17L17 USP17L6P USP17L3 FLRT3 ATG9A USP17L22 FXYD3 USP17L15 USP17L8 USP17L13	9.86e-11	1293	173	36	GO:0005789
GeneOntologyCellularComponent	endoplasmic reticulum subcompartment	USP17L7 LRAT USP17L21 USP17L4 USP17L2 APOO USP17L12 USP17L1 USP17L20 USP17L11 MARCHF2 SRD5A1 HLA-E HLA-F HLA-G USP17L5 TMTC2 MGLL CYP4F2 USP17L10 USP17L19 PNLDC1 PANX2 GBA2 RYR2 USP17L18 USP17L17 USP17L6P USP17L3 FLRT3 ATG9A USP17L22 FXYD3 USP17L15 USP17L8 USP17L13	1.12e-10	1299	173	36	GO:0098827
GeneOntologyCellularComponent	nuclear outer membrane-endoplasmic reticulum membrane network	USP17L7 LRAT USP17L21 USP17L4 USP17L2 APOO USP17L12 USP17L1 USP17L20 USP17L11 MARCHF2 SRD5A1 HLA-E HLA-F HLA-G USP17L5 TMTC2 MGLL CYP4F2 USP17L10 USP17L19 PNLDC1 PANX2 GBA2 RYR2 USP17L18 USP17L17 USP17L6P USP17L3 FLRT3 ATG9A USP17L22 FXYD3 USP17L15 USP17L8 USP17L13	2.02e-10	1327	173	36	GO:0042175
GeneOntologyCellularComponent	T cell receptor complex	TRGV2 TRGV3 TRGV4 TRGV5 TRBV14 TRBV7-7 TRBV7-4 TRBV7-3 TRBV7-2	8.88e-06	163	173	9	GO:0042101
GeneOntologyCellularComponent	intracellular cyclic nucleotide activated cation channel complex	CNGB3 CNGB1 CNGA4	1.90e-05	7	173	3	GO:0017071
GeneOntologyCellularComponent	MHC class Ib protein complex	HLA-E HLA-F HLA-G	1.90e-05	7	173	3	GO:0032398
GeneOntologyCellularComponent	Fc-epsilon receptor I complex	LILRA1 LILRA2 LILRA4	4.51e-05	9	173	3	GO:0032998
GeneOntologyCellularComponent	MHC class I protein complex	HLA-E HLA-F HLA-G	6.41e-05	10	173	3	GO:0042612
GeneOntologyCellularComponent	plasma membrane protein complex	LILRA1 LILRA2 CATSPERE HLA-E HLA-F TRGV2 HLA-G TRGV3 TRGV4 TRGV5 TRBV14 TRBV7-7 TRBV7-4 TRBV7-3 TRBV7-2 CACNG4 CALCRL LILRA4	9.39e-05	785	173	18	GO:0098797
GeneOntologyCellularComponent	Fc receptor complex	LILRA1 LILRA2 LILRA4	1.16e-04	12	173	3	GO:0032997
GeneOntologyCellularComponent	plasma membrane signaling receptor complex	TRGV2 TRGV3 TRGV4 TRGV5 TRBV14 TRBV7-7 TRBV7-4 TRBV7-3 TRBV7-2 CACNG4 CALCRL	1.67e-04	350	173	11	GO:0098802
GeneOntologyCellularComponent	MHC class I peptide loading complex	HLA-E HLA-F HLA-G	1.90e-04	14	173	3	GO:0042824
GeneOntologyCellularComponent	non-motile cilium membrane	CNGB1 CNGA4	2.03e-04	3	173	2	GO:0098804
GeneOntologyCellularComponent	membrane protein complex	BEST1 LILRA1 LILRA2 CATSPERE APOO HLA-E HLA-F TRGV2 HLA-G TRGV3 TRGV4 TRGV5 BCS1L RYR2 TRBV14 TRBV7-7 TRBV7-4 TRBV7-3 TRBV7-2 CNGB3 SLA2 CACNG4 CALCRL CNGB1 CNGA4 LILRA4	2.60e-04	1498	173	26	GO:0098796
GeneOntologyCellularComponent	cis-Golgi network membrane	HLA-E HLA-F HLA-G	3.48e-04	17	173	3	GO:0033106
GeneOntologyCellularComponent	Golgi medial cisterna	HLA-E HLA-F HLA-G	8.73e-04	23	173	3	GO:0005797
GeneOntologyCellularComponent	MHC protein complex	HLA-E HLA-F HLA-G	1.26e-03	26	173	3	GO:0042611
MousePheno	increased trophectoderm apoptosis	SMARCA5 USP17L2 USP17L15 USP17L13	3.89e-07	8	123	4	MP:0012119
MousePheno	spinal cord inflammation	HLA-E HLA-F HLA-G	3.60e-05	8	123	3	MP:0030987
MousePheno	increased thymus weight	USP17L2 RYR2 USP17L15 USP17L13	5.29e-05	24	123	4	MP:0004955
MousePheno	decreased macrophage nitric oxide production	HLA-E HLA-F HLA-G	5.37e-05	9	123	3	MP:0011077
MousePheno	decreased activated T cell number	HLA-E HLA-F HLA-G	5.37e-05	9	123	3	MP:0001830
Domain	HABP4_PAI-RBP1	USP17L7 USP17L21 USP17L2 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 USP17L13	8.31e-28	16	161	14	PF04774
Domain	HABP4_PAIRBP1-bd	USP17L7 USP17L21 USP17L2 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 USP17L13	8.31e-28	16	161	14	IPR006861
Domain	UCH	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP8 USP17L17 USP17L3 USP17L22 USP33 USP17L8 USP17L13	2.36e-25	71	161	20	PF00443
Domain	USP_2	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP8 USP17L17 USP17L3 USP17L22 USP33 USP17L8 USP17L13	2.36e-25	71	161	20	PS00973
Domain	USP_3	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP8 USP17L17 USP17L3 USP17L22 USP33 USP17L8 USP17L13	3.24e-25	72	161	20	PS50235
Domain	USP_dom	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP8 USP17L17 USP17L3 USP17L22 USP33 USP17L8 USP17L13	3.24e-25	72	161	20	IPR028889
Domain	Peptidase_C19_UCH	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP8 USP17L17 USP17L3 USP17L22 USP33 USP17L8 USP17L13	3.24e-25	72	161	20	IPR001394
Domain	USP_CS	USP17L7 USP17L21 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP8 USP17L17 USP17L3 USP17L22 USP33 USP17L8 USP17L13	2.45e-24	66	161	19	IPR018200
Domain	USP_1	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP8 USP17L17 USP17L3 USP17L22 USP33 USP17L8 USP17L13	8.72e-24	70	161	19	PS00972
Domain	GPCR_2_secretin-like_CS	ADGRB3 GCGR ADGRA2 CRHR1 ADGRF5 ADGRF3 CALCRL	1.37e-08	34	161	7	IPR017983
Domain	GPCR_2_extracellular_dom	ADGRB3 GCGR ADGRA2 CRHR1 ADGRF5 ADGRF3 CALCRL	4.56e-08	40	161	7	IPR001879
Domain	G_PROTEIN_RECEP_F2_1	ADGRB3 GCGR ADGRA2 CRHR1 ADGRF5 ADGRF3 CALCRL	4.56e-08	40	161	7	PS00649
Domain	G_PROTEIN_RECEP_F2_3	ADGRB3 GCGR ADGRA2 CRHR1 ADGRF5 ADGRF3 CALCRL	4.56e-08	40	161	7	PS50227
Domain	A1B_glyco/leuk_Ig-like_rcpt	LILRA1 LILRA3 LILRA2 LILRA4	7.87e-08	6	161	4	IPR016332
Domain	HRM	ADGRB3 GCGR ADGRA2 CRHR1 ADGRF3 CALCRL	1.20e-07	28	161	6	PF02793
Domain	7tm_2	ADGRB3 GCGR ADGRA2 CRHR1 ADGRF5 ADGRF3 CALCRL	2.27e-07	50	161	7	PF00002
Domain	G_PROTEIN_RECEP_F2_2	ADGRB3 GCGR ADGRA2 CRHR1 ADGRF5 ADGRF3 CALCRL	2.27e-07	50	161	7	PS00650
Domain	GPCR_2_secretin-like	ADGRB3 GCGR ADGRA2 CRHR1 ADGRF5 ADGRF3 CALCRL	8.17e-07	60	161	7	IPR000832
Domain	GPCR_2-like	ADGRB3 GCGR ADGRA2 CRHR1 ADGRF5 ADGRF3 CALCRL	8.17e-07	60	161	7	IPR017981
Domain	G_PROTEIN_RECEP_F2_4	ADGRB3 GCGR ADGRA2 CRHR1 ADGRF5 ADGRF3 CALCRL	9.16e-07	61	161	7	PS50261
Domain	Ig-like_fold	MPL IL10RA LILRA1 LILRA3 LILRA2 HLA-E HLA-F HLA-G ADGRA2 SLC4A2 SEMA3B ROBO1 ADGRF5 FLRT3 ADGRF3 HCFC2 NCR2 CNTN1 IGSF3 LILRA4	3.00e-06	706	161	20	IPR013783
Domain	-	MPL IL10RA LILRA1 LILRA3 LILRA2 HLA-E HLA-F HLA-G ADGRA2 SEMA3B ROBO1 ADGRF5 FLRT3 HCFC2 NCR2 CNTN1 IGSF3 LILRA4	1.72e-05	663	161	18	2.60.40.10
Domain	HormR	ADGRB3 GCGR CRHR1 CALCRL	5.84e-05	25	161	4	SM00008
Domain	Aquaporin_12	AQP12A AQP12B	7.39e-05	2	161	2	IPR023265
Domain	IG_LIKE	LILRA1 LILRA3 LILRA2 HLA-E HLA-F HLA-G ADGRA2 SEMA3B ROBO1 ADGRF5 NCR2 CNTN1 IGSF3 LILRA4	9.28e-05	491	161	14	PS50835
Domain	Ig-like_dom	LILRA1 LILRA3 LILRA2 HLA-E HLA-F HLA-G ADGRA2 SEMA3B ROBO1 ADGRF5 NCR2 CNTN1 IGSF3 LILRA4	1.20e-04	503	161	14	IPR007110
Domain	-	TRAF7 DMXL2 KATNB1 EML3 WDR91 PLAA KCTD3 SEMA3B FBXW5 DCAF11 RIC1	1.52e-04	333	161	11	2.130.10.10
Domain	WD_REPEATS_1	TRAF7 DMXL2 KATNB1 EML3 WDR91 PLAA KCTD3 FBXW5 DCAF11 RIC1	1.53e-04	278	161	10	PS00678
Domain	WD_REPEATS_2	TRAF7 DMXL2 KATNB1 EML3 WDR91 PLAA KCTD3 FBXW5 DCAF11 RIC1	1.58e-04	279	161	10	PS50082
Domain	WD_REPEATS_REGION	TRAF7 DMXL2 KATNB1 EML3 WDR91 PLAA KCTD3 FBXW5 DCAF11 RIC1	1.58e-04	279	161	10	PS50294
Domain	WD40/YVTN_repeat-like_dom	TRAF7 DMXL2 KATNB1 EML3 WDR91 PLAA KCTD3 SEMA3B FBXW5 DCAF11 RIC1	1.60e-04	335	161	11	IPR015943
Domain	GPS	ADGRB3 ADGRA2 ADGRF5 ADGRF3	2.02e-04	34	161	4	SM00303
Domain	Aquaporin_11/12	AQP12A AQP12B	2.20e-04	3	161	2	IPR016697
Domain	GPS	ADGRB3 ADGRA2 ADGRF5 ADGRF3	2.26e-04	35	161	4	PF01825
Domain	GPS	ADGRB3 ADGRA2 ADGRF5 ADGRF3	2.53e-04	36	161	4	PS50221
Domain	WD40_repeat_dom	TRAF7 DMXL2 KATNB1 EML3 WDR91 PLAA KCTD3 FBXW5 DCAF11 RIC1	2.61e-04	297	161	10	IPR017986
Domain	GPS	ADGRB3 ADGRA2 ADGRF5 ADGRF3	2.81e-04	37	161	4	IPR000203
Domain	cNMP-bd_CS	CNGB3 CNGB1 CNGA4	3.24e-04	16	161	3	IPR018488
Domain	WD40	TRAF7 DMXL2 KATNB1 EML3 WDR91 PLAA KCTD3 FBXW5 DCAF11	5.40e-04	268	161	9	SM00320
Domain	WD40_repeat	TRAF7 DMXL2 KATNB1 EML3 WDR91 PLAA KCTD3 FBXW5 DCAF11	6.01e-04	272	161	9	IPR001680
Domain	FERM_M	EPB41L4A FRMD1 KRIT1 MYO15A	6.55e-04	46	161	4	PF00373
Domain	MHC_I	HLA-E HLA-F HLA-G	7.46e-04	21	161	3	PF00129
Domain	MHC_I_a_a1/a2	HLA-E HLA-F HLA-G	7.46e-04	21	161	3	IPR001039
Domain	FERM_central	EPB41L4A FRMD1 KRIT1 MYO15A	8.33e-04	49	161	4	IPR019748
Domain	FERM_domain	EPB41L4A FRMD1 KRIT1 MYO15A	8.33e-04	49	161	4	IPR000299
Domain	FERM_1	EPB41L4A FRMD1 KRIT1 MYO15A	9.00e-04	50	161	4	PS00660
Domain	FERM_2	EPB41L4A FRMD1 KRIT1 MYO15A	9.00e-04	50	161	4	PS00661
Domain	FERM_3	EPB41L4A FRMD1 KRIT1 MYO15A	9.00e-04	50	161	4	PS50057
Domain	Band_41_domain	EPB41L4A FRMD1 KRIT1 MYO15A	9.00e-04	50	161	4	IPR019749
Domain	B41	EPB41L4A FRMD1 KRIT1 MYO15A	9.00e-04	50	161	4	SM00295
Domain	TPR_2	TMTC2 TTC3 TTC5 NAA16	9.00e-04	50	161	4	PF07719
Domain	TPR_2	TMTC2 TTC3 TTC5 NAA16	9.00e-04	50	161	4	IPR013105
Domain	IGc2	LILRA1 LILRA3 LILRA2 ROBO1 ADGRF5 CNTN1 IGSF3 LILRA4	1.01e-03	235	161	8	SM00408
Domain	Ig_sub2	LILRA1 LILRA3 LILRA2 ROBO1 ADGRF5 CNTN1 IGSF3 LILRA4	1.01e-03	235	161	8	IPR003598
Domain	MHC_I_a_C	HLA-E HLA-F	1.08e-03	6	161	2	IPR010579
Domain	MHC_I_C	HLA-E HLA-F	1.08e-03	6	161	2	PF06623
Domain	IG	LILRA1 LILRA3 LILRA2 ADGRA2 SEMA3B ROBO1 ADGRF5 NCR2 CNTN1 IGSF3 LILRA4	1.09e-03	421	161	11	SM00409
Domain	Ig_sub	LILRA1 LILRA3 LILRA2 ADGRA2 SEMA3B ROBO1 ADGRF5 NCR2 CNTN1 IGSF3 LILRA4	1.09e-03	421	161	11	IPR003599
Domain	-	HLA-E HLA-F HLA-G	1.11e-03	24	161	3	3.30.500.10
Domain	MHC_I-like_Ag-recog	HLA-E HLA-F HLA-G	1.11e-03	24	161	3	IPR011161
Domain	WD40	TRAF7 DMXL2 KATNB1 EML3 WDR91 PLAA FBXW5 DCAF11	1.86e-03	259	161	8	PF00400
Domain	CNMP_BINDING_1	CNGB3 CNGB1 CNGA4	2.60e-03	32	161	3	PS00888
Domain	CNMP_BINDING_2	CNGB3 CNGB1 CNGA4	2.60e-03	32	161	3	PS00889
Domain	cNMP	CNGB3 CNGB1 CNGA4	3.09e-03	34	161	3	SM00100
Domain	cNMP_binding	CNGB3 CNGB1 CNGA4	3.09e-03	34	161	3	PF00027
Domain	cNMP-bd_dom	CNGB3 CNGB1 CNGA4	3.36e-03	35	161	3	IPR000595
Domain	CNMP_BINDING_3	CNGB3 CNGB1 CNGA4	3.36e-03	35	161	3	PS50042
Domain	Ig_2	LILRA1 LILRA3 LILRA2 LILRA4	3.65e-03	73	161	4	PF13895
Domain	cNMP-bd-like	CNGB3 CNGB1 CNGA4	4.25e-03	38	161	3	IPR018490
Domain	MHC_I/II-like_Ag-recog	HLA-E HLA-F HLA-G	4.25e-03	38	161	3	IPR011162
Domain	ABC_transporter_CS	ABCC11 ABCA7 ABCC2	5.64e-03	42	161	3	IPR017871
Domain	ig	LILRA1 LILRA3 LILRA2 SEMA3B ADGRF5 LILRA4	6.15e-03	190	161	6	PF00047
Domain	Immunoglobulin	LILRA1 LILRA3 LILRA2 SEMA3B ADGRF5 LILRA4	6.15e-03	190	161	6	IPR013151
Domain	MIP	AQP12A AQP12B	6.28e-03	14	161	2	PF00230
Domain	IMPORTIN_B_NT	IPO8 XPO6	6.28e-03	14	161	2	PS50166
Domain	MIP	AQP12A AQP12B	6.28e-03	14	161	2	PS00221
Domain	-	ARID4B JARID2	7.20e-03	15	161	2	1.10.150.60
Domain	BRIGHT	ARID4B JARID2	7.20e-03	15	161	2	SM00501
Domain	ARID_dom	ARID4B JARID2	7.20e-03	15	161	2	IPR001606
Domain	ARID	ARID4B JARID2	7.20e-03	15	161	2	PS51011
Domain	-	AQP12A AQP12B	7.20e-03	15	161	2	1.20.1080.10
Domain	Aquaporin-like	AQP12A AQP12B	7.20e-03	15	161	2	IPR023271
Domain	MIP	AQP12A AQP12B	7.20e-03	15	161	2	IPR000425
Domain	IBN_N	IPO8 XPO6	7.20e-03	15	161	2	PF03810
Domain	ARID	ARID4B JARID2	7.20e-03	15	161	2	PF01388
Domain	TPR_1	TMTC2 TTC3 TTC5 NAA16	7.66e-03	90	161	4	IPR001440
Domain	TPR_1	TMTC2 TTC3 TTC5 NAA16	7.66e-03	90	161	4	PF00515
Domain	GRAM	TBC1D9B TBC1D9	8.19e-03	16	161	2	SM00568
Domain	IBN_N	IPO8 XPO6	8.19e-03	16	161	2	SM00913
Domain	ABC_tran	ABCC11 ABCA7 ABCC2	8.19e-03	48	161	3	PF00005
Domain	-	CNGB3 CNGB1 CNGA4	8.19e-03	48	161	3	2.60.120.10
Domain	ABC_TRANSPORTER_2	ABCC11 ABCA7 ABCC2	8.19e-03	48	161	3	PS50893
Pathway	REACTOME_RAS_PROCESSING	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	4.19e-28	45	124	19	MM15671
Pathway	REACTOME_UB_SPECIFIC_PROCESSING_PROTEASES	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP8 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP33 USP17L8 USP17L13	1.72e-17	191	124	21	MM15289
Pathway	REACTOME_DEUBIQUITINATION	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP8 USP17L17 USP17L6P USP17L3 KDM1B USP17L22 USP17L15 USP33 USP17L8 USP17L13	8.90e-16	262	124	22	MM15286
Pathway	REACTOME_UB_SPECIFIC_PROCESSING_PROTEASES	USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP8 USP17L17 USP17L3 USP17L22 USP17L15 USP33 USP17L8 USP17L13	4.85e-15	221	124	20	M27578
Pathway	REACTOME_DEUBIQUITINATION	USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP8 USP17L17 USP17L3 KDM1B USP17L22 USP17L15 USP33 USP17L8 USP17L13	1.49e-13	299	124	21	M27574
Pathway	REACTOME_MAPK_FAMILY_SIGNALING_CASCADES	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	4.06e-11	318	124	19	MM15278
Pathway	KEGG_MEDICUS_PATHOGEN_KSHV_MIR1_2_TO_ANTIGEN_PROCESSING_AND_PRESENTATION_BY_MHC_CLASS_I_MOLECULES	HLA-E HLA-F HLA-G	1.30e-05	6	124	3	M47468
Pathway	KEGG_MEDICUS_PATHOGEN_HTLV_1_P12_TO_ANTIGEN_PROCESSING_AND_PRESENTATION_BY_MHC_CLASS_I_MOLECULES	HLA-E HLA-F HLA-G	2.27e-05	7	124	3	M47582
Pathway	KEGG_MEDICUS_PATHOGEN_HPV_E5_TO_ANTIGEN_PROCESSING_AND_PRESENTATION_BY_MHC_CLASS_I_MOLECULES	HLA-E HLA-F HLA-G	2.27e-05	7	124	3	M47530
Pathway	REACTOME_ENDOSOMAL_VACUOLAR_PATHWAY	HLA-E HLA-F HLA-G	5.37e-05	9	124	3	MM14527
Pathway	REACTOME_POST_TRANSLATIONAL_PROTEIN_MODIFICATION	USP17L7 USP17L21 USP17L4 USP17L2 HDAC4 USP17L12 USP17L1 ADAMTS3 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP8 ST3GAL6 USP17L17 FBXW5 USP17L6P USP17L3 DCAF11 KDM1B USP17L22 USP17L15 USP33 USP17L8 USP17L13	5.99e-05	1389	124	27	MM15307
Pathway	REACTOME_ENDOSOMAL_VACUOLAR_PATHWAY	HLA-E HLA-F HLA-G	1.04e-04	11	124	3	M525
Pathway	KEGG_MEDICUS_REFERENCE_ANTIGEN_PROCESSING_AND_PRESENTATION_BY_MHC_CLASS_I_MOLECULES	HLA-E HLA-F HLA-G	1.38e-04	12	124	3	M47529
Pathway	REACTOME_IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL	LILRA1 LILRA3 LILRA2 HLA-E HLA-F HLA-G NCR2 LILRA4	2.73e-04	190	124	8	M8240
Pathway	REACTOME_POST_TRANSLATIONAL_PROTEIN_MODIFICATION	USP17L21 USP17L4 USP17L2 HDAC4 USP17L12 USP17L1 ADAMTS3 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP8 ST3GAL6 USP17L17 FBXW5 USP17L3 DCAF11 KDM1B USP17L22 USP17L15 USP33 USP17L8 USP17L13	4.06e-04	1475	124	26	M19806
Pathway	REACTOME_ER_PHAGOSOME_PATHWAY	HLA-E HLA-F HLA-G	4.92e-04	18	124	3	MM14525
Pathway	BIOCARTA_CTL_PATHWAY	HLA-E HLA-F HLA-G	6.79e-04	20	124	3	MM1374
Pubmed	DUB-1, a deubiquitinating enzyme with growth-suppressing activity.	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	1.63e-42	21	175	19	8622927
Pubmed	DUB-1A, a novel deubiquitinating enzyme subfamily member, is polyubiquitinated and cytokine-inducible in B-lymphocytes.	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	1.63e-42	21	175	19	14583620
Pubmed	DUB-2A, a new member of the DUB subfamily of hematopoietic deubiquitinating enzymes.	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	1.63e-42	21	175	19	11468161
Pubmed	The murine DUB-1 gene is specifically induced by the betac subunit of interleukin-3 receptor.	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	1.63e-42	21	175	19	8756639
Pubmed	Lymphocyte-specific murine deubiquitinating enzymes induced by cytokines.	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	1.63e-42	21	175	19	12447969
Pubmed	DUB-1, a fate determinant of dynein heavy chain in B-lymphocytes, is regulated by the ubiquitin-proteasome pathway.	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	1.63e-42	21	175	19	18980247
Pubmed	JAK2 is required for induction of the murine DUB-1 gene.	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	1.19e-41	22	175	19	9154835
Pubmed	DUB-2 is a member of a novel family of cytokine-inducible deubiquitinating enzymes.	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	3.26e-40	24	175	19	8995226
Pubmed	Interleukin 1 receptor signaling regulates DUBA expression and facilitates Toll-like receptor 9-driven antiinflammatory cytokine production.	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	1.35e-39	25	175	19	21115691
Pubmed	Decabromodiphenyl ethane affects embryonic development by interfering with nuclear F-actin in zygotes and leads to cognitive and social disorders in offspring mice.	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	5.01e-39	26	175	19	35816173
Pubmed	Cdc25A and Dub3 in a high-stakes balancing act.	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	1.91e-38	33	175	20	20228807
Pubmed	The DUB/USP17 deubiquitinating enzymes: a gene family within a tandemly repeated sequence, is also embedded within the copy number variable beta-defensin cluster.	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	4.62e-38	34	175	20	20403174
Pubmed	DUB-3, a cytokine-inducible deubiquitinating enzyme that blocks proliferation.	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	4.62e-38	34	175	20	14699124
Pubmed	The DUB/USP17 deubiquitinating enzymes, a multigene family within a tandemly repeated sequence.	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	4.62e-38	34	175	20	15780755
Pubmed	USP17 regulates Ras activation and cell proliferation by blocking RCE1 activity.	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	4.62e-38	34	175	20	19188362
Pubmed	Unstable transmission of the RS447 human megasatellite tandem repetitive sequence that contains the USP17 deubiquitinating enzyme gene.	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	4.62e-38	34	175	20	11941478
Pubmed	Hyaluronan- and RNA-binding deubiquitinating enzymes of USP17 family members associated with cell viability.	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	4.62e-38	34	175	20	17109758
Pubmed	The deubiquitinating enzyme USP17 is highly expressed in tumor biopsies, is cell cycle regulated, and is required for G1-S progression.	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	4.62e-38	34	175	20	20388806
Pubmed	Polyclonal and monoclonal antibodies specific for USP17, a proapoptotic deubiquitinating enzyme.	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	4.62e-38	34	175	20	20715989
Pubmed	Human megasatellite DNA RS447: copy-number polymorphisms and interspecies conservation.	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	4.62e-38	34	175	20	9806828
Pubmed	The ubiquitin-specific protease 17 is involved in virus-triggered type I IFN signaling.	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	4.62e-38	34	175	20	20368735
Pubmed	The RS447 human megasatellite tandem repetitive sequence encodes a novel deubiquitinating enzyme with a functional promoter.	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	4.62e-38	34	175	20	10936051
Pubmed	The deubiquitinating enzyme USP17 is essential for GTPase subcellular localization and cell motility.	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	4.62e-38	34	175	20	21448158
Pubmed	Cytokine-regulated protein degradation by the ubiquitination system.	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	1.07e-37	35	175	20	16611142
Pubmed	Lys-63-specific deubiquitination of SDS3 by USP17 regulates HDAC activity.	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	1.07e-37	35	175	20	21239494
Pubmed	Minor Splicing Factors Zrsr1 and Zrsr2 Are Essential for Early Embryo Development and 2-Cell-Like Conversion.	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	1.51e-37	29	175	19	32527007
Pubmed	The deubiquitinating enzyme USP17 blocks N-Ras membrane trafficking and activation but leaves K-Ras unaffected.	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	2.40e-37	36	175	20	20147298
Pubmed	Ubiquitin hydrolase Dub3 promotes oncogenic transformation by stabilizing Cdc25A.	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	5.21e-37	37	175	20	20228808
Pubmed	DUX is a non-essential synchronizer of zygotic genome activation.	USP17L7 USP17L21 PRAMEF33 USP17L4 PRAMEF10 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	9.35e-36	50	175	21	31806660
Pubmed	High Dub3 expression in mouse ESCs couples the G1/S checkpoint to pluripotency.	USP17L7 USP17L4 USP17L2 USP17L1 USP17L6P USP17L3 USP17L15 USP17L8	1.56e-17	10	175	8	24207026
Pubmed	Cell cycle-dependent expression of Dub3, Nanog and the p160 family of nuclear receptor coactivators (NCoAs) in mouse embryonic stem cells.	USP17L7 USP17L4 USP17L2 USP17L1 USP17L6P USP17L3 USP17L15 USP17L8	1.70e-16	12	175	8	24695638
Pubmed	ES cell neural differentiation reveals a substantial number of novel ESTs.	USP17L7 USP17L4 USP17L2 USP17L1 USP17L6P USP17L3 USP17L15 USP17L8	1.02e-15	14	175	8	11793228
Pubmed	USP7 represses lineage differentiation genes in mouse embryonic stem cells by both catalytic and noncatalytic activities.	USP17L7 USP17L21 USP17L4 PRAMEF10 USP17L2 APOO USP17L12 USP17L1 USP17L20 USP17L11 HLA-E HLA-F HLA-G USP17L5 USP17L10 USP17L19 EPB41L4A USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	8.22e-15	674	175	25	37196079
Pubmed	CDK4/6-dependent activation of DUB3 regulates cancer metastasis through SNAIL1.	USP17L7 USP17L4 USP17L2 USP17L1 USP17L6P USP17L3 USP17L15 USP17L8	2.52e-14	19	175	8	28067227
Pubmed	Human and mouse proteases: a comparative genomic approach.	USP17L7 USP17L4 OVCH2 USP17L2 USP17L1 USP8 USP17L6P USP17L3 USP17L15 USP33 USP17L8	3.41e-13	81	175	11	12838346
Pubmed	Neuroprotection from stroke in the absence of MHCI or PirB.	LILRA1 LILRA2 HLA-E HLA-F HLA-G	2.34e-09	12	175	5	22445338
Pubmed	The majority of H2-M3 is retained intracellularly in a peptide-receptive state and traffics to the cell surface in the presence of N-formylated peptides.	HLA-E HLA-F HLA-G	1.25e-07	3	175	3	10430630
Pubmed	Characterization of a new subfamily of class I genes in the H-2 complex of the mouse.	HLA-E HLA-F HLA-G	1.25e-07	3	175	3	3378834
Pubmed	Reduced expression of the murine HLA-G homolog Qa-2 is associated with malignancy, epithelial-mesenchymal transition and stemness in breast cancer cells.	HLA-E HLA-F HLA-G	1.25e-07	3	175	3	28740236
Pubmed	Comparative genomic aspects of rat, mouse and human MHC class I gene regions.	HLA-E HLA-F HLA-G	1.25e-07	3	175	3	11173841
Pubmed	Removal of Qa-2 antigen alters the Ped gene phenotype of preimplantation mouse embryos.	HLA-E HLA-F HLA-G	1.25e-07	3	175	3	1327207
Pubmed	Fine map of a region homologous to the rat grc complex in the TL region of the mouse.	HLA-E HLA-F HLA-G	1.25e-07	3	175	3	8428772
Pubmed	CTL and sequence analyses of MHC class IB antigens Qa1(c) (H2-T23(r)) and Qa1(d) (H2-T23(f)).	HLA-E HLA-F HLA-G	1.25e-07	3	175	3	10369933
Pubmed	Antigen-presenting cells for naive transgenic gamma delta T cells. Potent activation by activated alpha beta T cells.	HLA-E HLA-F HLA-G	1.25e-07	3	175	3	7561093
Pubmed	Critical role of Qa1b in the protection of mature dendritic cells from NK cell-mediated killing.	HLA-E HLA-F HLA-G	1.25e-07	3	175	3	18028286
Pubmed	Organization and structure of the H-2M4-M8 class I genes in the mouse major histocompatibility complex.	HLA-E HLA-F HLA-G	1.25e-07	3	175	3	8319975
Pubmed	Expression of nonclassical class I major histocompatibility genes defines a tripartite organization of the mouse vomeronasal system.	HLA-E HLA-F HLA-G	1.25e-07	3	175	3	18322080
Pubmed	Analysis of litter size and weight in mice differing in Ped gene phenotype and the Q region of the H-2 complex.	HLA-E HLA-F HLA-G	1.25e-07	3	175	3	1865393
Pubmed	Hyperconservation of the N-formyl peptide binding site of M3: evidence that M3 is an old eutherian molecule with conserved recognition of a pathogen-associated molecular pattern.	HLA-E HLA-F HLA-G	1.25e-07	3	175	3	12847252
Pubmed	Linkage of the preimplantation-embryo-development (Ped) gene to the mouse major histocompatibility complex (MHC).	HLA-E HLA-F HLA-G	1.25e-07	3	175	3	3593832
Pubmed	Duplicated gene pairs and alleles of class I genes in the Qa2 region of the murine major histocompatibility complex: a comparison.	HLA-E HLA-F HLA-G	1.25e-07	3	175	3	3004940
Pubmed	Murine MHC class Ib gene, H2-M2, encodes a conserved surface-expressed glycoprotein.	HLA-E HLA-F HLA-G	1.25e-07	3	175	3	15045471
Pubmed	HMT, encoded by H-2M3, is a neoclassical major histocompatibility class I antigen.	HLA-E HLA-F HLA-G	1.25e-07	3	175	3	8464890
Pubmed	A cDNA clone encoding the mouse Qa-1a histocompatibility antigen and proposed structure of the putative peptide binding site.	HLA-E HLA-F HLA-G	1.25e-07	3	175	3	8245452
Pubmed	Identification of two major histocompatibility complex class Ib genes, Q7 and Q9, as the Ped gene in the mouse.	HLA-E HLA-F HLA-G	1.25e-07	3	175	3	10208972
Pubmed	BLyF, a novel cell-type- and stage-specific regulator of the B-lymphocyte gene mb-1.	HLA-E HLA-F HLA-G	1.25e-07	3	175	3	1545794
Pubmed	Extension of the H-2 TLb molecular map. Isolation and characterization of T13, T14, and T15 from the C57BL/6 mouse.	HLA-E HLA-F HLA-G	1.25e-07	3	175	3	2831142
Pubmed	Two "Qa" specificities: Qa-m7 and Qa-m8 defined by monoclonal antibodies.	HLA-E HLA-F HLA-G	1.25e-07	3	175	3	6190932
Pubmed	Analysis of the Qa-4 allodeterminant.	HLA-E HLA-F HLA-G	1.25e-07	3	175	3	2581893
Pubmed	Class Ib MHC-Mediated Immune Interactions Play a Critical Role in Maintaining Mucosal Homeostasis in the Mammalian Large Intestine.	HLA-E HLA-F HLA-G	1.25e-07	3	175	3	34911745
Pubmed	Repression of the nonclassical MHC class I gene H2-M1 by cis-acting silencer DNA elements.	HLA-E HLA-F HLA-G	1.25e-07	3	175	3	8753857
Pubmed	Combinatorial coexpression of neural and immune multigene families in mouse vomeronasal sensory neurons.	HLA-E HLA-F HLA-G	1.25e-07	3	175	3	12620187
Pubmed	Expression in L cells of transfected class I genes from the mouse major histocompatibility complex.	HLA-E HLA-F HLA-G	1.25e-07	3	175	3	2991930
Pubmed	Polymorphism within a TCRAV family influences the repertoire through class I/II restriction.	HLA-E HLA-F HLA-G	1.25e-07	3	175	3	9570535
Pubmed	Peptide Binding to HLA-E Molecules in Humans, Nonhuman Primates, and Mice Reveals Unique Binding Peptides but Remarkably Conserved Anchor Residues.	HLA-E HLA-F HLA-G	1.25e-07	3	175	3	33020145
Pubmed	Identification of the Ped gene at the molecular level: the Q9 MHC class I transgene converts the Ped slow to the Ped fast phenotype.	HLA-E HLA-F HLA-G	1.25e-07	3	175	3	7819451
Pubmed	Novel mRNA species from a Q-subregion class-I gene of the murine major histocompatibility complex.	HLA-E HLA-F HLA-G	1.25e-07	3	175	3	3443307
Pubmed	Qa-1-Restricted CD8+ T Cells Can Compensate for the Absence of Conventional T Cells during Viral Infection.	HLA-E HLA-F HLA-G	1.25e-07	3	175	3	30970256
Pubmed	Protein expression and peptide binding suggest unique and interacting functional roles for HLA-E, F, and G in maternal-placental immune recognition.	HLA-E HLA-F HLA-G	1.25e-07	3	175	3	12874228
Pubmed	HLA-E, HLA-F, and HLA-G polymorphism: genomic sequence defines haplotype structure and variation spanning the nonclassical class I genes.	HLA-E HLA-F HLA-G	1.25e-07	3	175	3	16570139
Pubmed	Role of the Ped gene and apoptosis genes in control of preimplantation development.	HLA-E HLA-F HLA-G	1.25e-07	3	175	3	9604770
Pubmed	Evolution and molecular interactions of major histocompatibility complex (MHC)-G, -E and -F genes.	HLA-E HLA-F HLA-G	1.25e-07	3	175	3	35925520
Pubmed	Sequence of the mouse Q4 class I gene and characterization of the gene product.	HLA-E HLA-F HLA-G	1.25e-07	3	175	3	3335397
Pubmed	HLA-G, -E and -F: allelism, function and evolution.	HLA-E HLA-F HLA-G	1.25e-07	3	175	3	17157219
Pubmed	Syngeneic tumor immunizations produce Qa antibodies. Discovery of a new Qa antigen, Qa-6.	HLA-E HLA-F HLA-G	1.25e-07	3	175	3	7173999
Pubmed	Rat RT1 orthologs of mouse H2-M class Ib genes.	HLA-E HLA-F HLA-G	1.25e-07	3	175	3	7797270
Pubmed	Tissue-specific expression of cell-surface Qa-2 antigen from a transfected Q7b gene of C57BL/10 mice.	HLA-E HLA-F HLA-G	1.25e-07	3	175	3	3502706
Pubmed	Correction of defects responsible for impaired Qa-2 class Ib MHC expression on melanoma cells protects mice from tumor growth.	HLA-E HLA-F HLA-G	1.25e-07	3	175	3	12707328
Pubmed	Recognition of the nonclassical MHC class I molecule H2-M3 by the receptor Ly49A regulates the licensing and activation of NK cells.	HLA-E HLA-F HLA-G	1.25e-07	3	175	3	23142773
Pubmed	Qa-1b Modulates Resistance to Anti-PD-1 Immune Checkpoint Blockade in Tumors with Defects in Antigen Processing.	HLA-E HLA-F HLA-G	1.25e-07	3	175	3	33674442
Pubmed	H-2M3 encodes the MHC class I molecule presenting the maternally transmitted antigen of the mouse.	HLA-E HLA-F HLA-G	1.25e-07	3	175	3	1855254
Pubmed	Maternally transmitted antigen.	HLA-E HLA-F HLA-G	1.25e-07	3	175	3	3515868
Pubmed	The murine CD94/NKG2 ligand, Qa-1b, is a high-affinity, functional ligand for the CD8αα homodimer.	HLA-E HLA-F HLA-G	1.25e-07	3	175	3	31992596
Pubmed	Biochemical characterization of the molecules reactive with Qa-6 antiserum and the monoclonal antibody 20-8-4: evidence for structural similarity with the Qa-2 molecule.	HLA-E HLA-F HLA-G	1.25e-07	3	175	3	2413118
Pubmed	[Mifepristone inhibits the progesterone-induced expressions of HLA-G, -E, -F genes in trophoblasts during first trimester].	HLA-E HLA-F HLA-G	1.25e-07	3	175	3	22490650
Pubmed	Activated T cells transcribe an alternatively spliced mRNA encoding a soluble form of Qa-2 antigen.	HLA-E HLA-F HLA-G	1.25e-07	3	175	3	2249652
Pubmed	H2-M3-restricted T cells participate in the priming of antigen-specific CD4+ T cells.	HLA-E HLA-F HLA-G	1.25e-07	3	175	3	17015693
Pubmed	Widespread transcription of a Qa region gene in adult mice.	HLA-E HLA-F HLA-G	1.25e-07	3	175	3	2439640
Pubmed	Mta, the maternally transmitted antigen, is determined jointly by the chromosomal Hmt and the extrachromosomal Mtf genes.	HLA-E HLA-F HLA-G	1.25e-07	3	175	3	3511170
Pubmed	Differential expression of Ped gene candidates in preimplantation mouse embryos.	HLA-E HLA-F HLA-G	1.25e-07	3	175	3	9746747
Pubmed	NKG2A Blockade Potentiates CD8 T Cell Immunity Induced by Cancer Vaccines.	HLA-E HLA-F HLA-G	1.25e-07	3	175	3	30503208
Pubmed	Polymorphism and conservation of the genes encoding Qa1 molecules.	HLA-E HLA-F HLA-G	1.25e-07	3	175	3	15517242
Pubmed	A new H-2-linked class I gene whose expression depends on a maternally inherited factor.	HLA-E HLA-F HLA-G	1.25e-07	3	175	3	6646216
Pubmed	Positive selecting cell type determines the phenotype of MHC class Ib-restricted CD8+ T cells.	HLA-E HLA-F HLA-G	1.25e-07	3	175	3	21788511
Pubmed	Characterization of a Q subregion gene in the murine major histocompatibility complex.	HLA-E HLA-F HLA-G	1.25e-07	3	175	3	2983348
Pubmed	Expression of the Q8/9d gene by T cells of the mouse.	HLA-E HLA-F HLA-G	1.25e-07	3	175	3	2789189
Pubmed	Comparative structure of two duplicated T1a class I genes (T10c and 37) of the murine H-2d MHC. Implications on the evolution of the T1a region.	HLA-E HLA-F HLA-G	1.25e-07	3	175	3	1968929
Pubmed	A low polymorphic mouse H-2 class I gene from the Tla complex is expressed in a broad variety of cell types.	HLA-E HLA-F HLA-G	1.25e-07	3	175	3	3036997
Pubmed	Expression of the mouse MHC class Ib H2-T11 gene product, a paralog of H2-T23 (Qa-1) with shared peptide-binding specificity.	HLA-E HLA-F HLA-G	1.25e-07	3	175	3	24958902
Pubmed	H2-M3-restricted CD8+ T cells augment CD4+ T-cell responses by promoting DC maturation.	HLA-E HLA-F HLA-G	1.25e-07	3	175	3	20162552
Cytoband	4p16.1	USP17L21 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L22 USP17L15 USP17L13	8.08e-20	79	175	14	4p16.1
Cytoband	Ensembl 112 genes in cytogenetic band chr4p16	HGFAC USP17L21 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P OTOP1 USP17L22 USP17L15 USP17L13	4.79e-16	222	175	16	chr4p16
Cytoband	7p14	TRGV2 TRGV3 TRGV4 TRGV5	5.17e-06	30	175	4	7p14
Cytoband	8p23.1	USP17L7 USP17L4 USP17L2 USP17L1 USP17L3 USP17L8	2.96e-05	154	175	6	8p23.1
Cytoband	2q37.3	AQP12A HDAC4 AQP12B ANO7	2.22e-04	77	175	4	2q37.3
Cytoband	19q13.4	LILRA1 LILRA3 LILRA2 LILRA4	2.45e-04	79	175	4	19q13.4
Cytoband	Ensembl 112 genes in cytogenetic band chr8p23	USP17L7 USP17L4 USP17L2 USP17L1 USP17L3 USP17L8	2.94e-04	234	175	6	chr8p23
Cytoband	6p21.3	DHX16 HLA-E HLA-F HLA-G MSH5 PHF1	4.17e-04	250	175	6	6p21.3
Cytoband	7q34	TRBV14 TRBV7-7 TRBV7-4 TRBV7-3 TRBV7-2	4.71e-04	167	175	5	7q34
Cytoband	Ensembl 112 genes in cytogenetic band chr7q34	TRBV14 TRBV7-7 TRBV7-4 TRBV7-3 TRBV7-2	7.48e-04	185	175	5	chr7q34
GeneFamily	CD molecules\|Activating leukocyte immunoglobulin like receptors	LILRA1 LILRA3 LILRA2 LILRA4	2.83e-08	6	121	4	1181
GeneFamily	T cell receptor gamma locus at 7p14	TRGV2 TRGV3 TRGV4 TRGV5	1.27e-05	22	121	4	375
GeneFamily	Cyclic nucleotide gated channels	CNGB3 CNGB1 CNGA4	3.39e-05	10	121	3	250
GeneFamily	T cell receptor beta locus at 7q34	TRBV14 TRBV7-7 TRBV7-4 TRBV7-3 TRBV7-2	2.95e-04	87	121	5	372
GeneFamily	Ankyrin repeat domain containing\|FERM domain containing	EPB41L4A FRMD1 KRIT1 MYO15A	3.47e-04	50	121	4	1293
GeneFamily	WD repeat domain containing	TRAF7 DMXL2 KATNB1 EML3 WDR91 PLAA FBXW5 DCAF11	3.84e-04	262	121	8	362
GeneFamily	Adhesion G protein-coupled receptors, subfamily F	ADGRF5 ADGRF3	4.38e-04	5	121	2	916
GeneFamily	C1-set domain containing	HLA-E HLA-F HLA-G	2.78e-03	42	121	3	591
GeneFamily	Histocompatibility complex\|C1-set domain containing	HLA-E HLA-F HLA-G	3.17e-03	44	121	3	588
GeneFamily	ATP binding cassette subfamily C	ABCC11 ABCC2	3.30e-03	13	121	2	807
GeneFamily	WD repeat domain containing\|GRAM domain containing\|BEACH domain containing	TBC1D9B TBC1D9	3.30e-03	13	121	2	1146
GeneFamily	Aquaporins	AQP12A AQP12B	3.84e-03	14	121	2	305
GeneFamily	AT-rich interaction domain containing	ARID4B JARID2	4.41e-03	15	121	2	418
GeneFamily	Ubiquitin specific peptidases	USP17L2 USP8 USP33	6.26e-03	56	121	3	366
GeneFamily	Tetratricopeptide repeat domain containing\|Bardet-Biedl syndrome associated\|BBSome	TMTC2 TTC3 TTC5 NAA16	7.46e-03	115	121	4	769
Coexpression	MADAN_DPPA4_TARGETS	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	4.02e-24	86	171	19	MM1312
Coexpression	GRAESSMANN_RESPONSE_TO_MC_AND_SERUM_DEPRIVATION_DN	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 PKP1 USP17L22 USP17L15 USP17L8 USP17L13	2.43e-23	112	171	20	MM1095
Coexpression	GERY_CEBP_TARGETS	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	9.97e-19	160	171	19	MM1155
Coexpression	GRAESSMANN_RESPONSE_TO_MC_AND_DOXORUBICIN_UP	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 DAPK1 USP17L10 USP17L19 USP17L18 USP17L17 C11orf68 USP17L6P USP17L3 PKP1 SESN2 USP17L22 USP17L15 USP17L8 USP17L13	4.44e-11	647	171	23	MM981
Coexpression	BRUINS_UVC_RESPONSE_LATE	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 DAPK1 USP17L10 USP17L19 MSH5 ADGRA2 BCS1L KRIT1 USP17L18 SIAE ST3GAL6 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 LRRC17 USP17L13	1.81e-08	1198	171	27	MM1062
Coexpression	MARSON_BOUND_BY_FOXP3_STIMULATED	USP17L7 IL10RA USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 MSH5 USP17L18 USP8 SIAE USP17L17 USP17L6P USP17L3 SESN2 TTC5 USP17L22 USP17L15 USP17L8 USP17L13	3.38e-08	1072	171	25	MM1031
Coexpression	GRAESSMANN_APOPTOSIS_BY_DOXORUBICIN_UP	USP17L7 COL4A4 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 DAPK1 USP17L10 USP17L19 USP17L18 USP17L17 C11orf68 USP17L6P USP17L3 PKP1 SESN2 USP17L22 USP17L15 SF3B5 USP17L8 USP17L13	4.27e-07	1226	171	25	MM979
Coexpression	IWANAGA_CARCINOGENESIS_BY_KRAS_UP	SMARCA5 IPO8 HLA-E HLA-F HLA-G G2E3 WDR91 FAM120A SLA2	5.05e-06	192	171	9	MM752
Coexpression	TABULA_MURIS_SENIS_MARROW_MEGAKARYOCYTE_ERYTHROID_PROGENITOR_CELL_AGEING	LILRA1 LILRA2 HLA-E HLA-F HLA-G	1.86e-05	50	171	5	MM3805
Coexpression	DCA_UP.V1_DN	IL10RA MARCHF2 MSH5 WDR91 RASL10A KCTD3 PKP1 ADGRF5	3.05e-05	185	171	8	M2760
Coexpression	KIM_GLIS2_TARGETS_UP	LILRA1 LILRA2 HLA-E HLA-F HLA-G IRF1	5.67e-05	102	171	6	MM1064
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Macula_Densa_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	CPEB2 COL4A4 SGSM1 MECOM DAPK1 MGLL LRP1B CNTN1	5.11e-07	184	168	8	d33de57876817050b294f2ecb0a4eb0634cfa7f0
ToppCell	COVID-19-kidney-TAL\|kidney / Disease (COVID-19 only), tissue and cell type	CPEB2 COL4A4 CLDN14 MECOM DAPK1 MGLL LRP1B HIVEP3	8.24e-07	196	168	8	04f5eb206ed3016a737609a3ebac0c1fcabb94ef
ToppCell	10x5'-bone_marrow-Lymphocytic_T_CD8-Tem/emra_CD8\|bone_marrow / Manually curated celltypes from each tissue	HLA-E HLA-F TRGV2 TRGV3 TRGV4 IRF1 TRBV14 SLA2	8.24e-07	196	168	8	f23c33ad10f933250be98e8389a9aa278e876f96
ToppCell	distal-Epithelial-Alveolar_Epithelial_Type_1-2\|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	COL4A4 HLA-G MGLL SEMA3B CACNG4 FLRT3 FXYD3 IGSF3	9.24e-07	199	168	8	c1daa481f88d5281b6b5ea8ec8bb70cc0907d613
ToppCell	droplet-Liver-LIVER_HEP-30m-Myeloid\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MPL IL10RA EPB41L4A TBC1D9 HIVEP3 SEMA3B SLC45A2	4.16e-06	172	168	7	3f784aed340b50ddbec3f7dc0a5279180d38a2bb
ToppCell	droplet-Liver-LIVER_HEP-30m-Myeloid-Kupffer_cell\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MPL LHFPL4 EPB41L4A TBC1D9 SEMA3B FXYD3 CNGB1	4.84e-06	176	168	7	5e46a09a36b9645b1b1fcb0b64bd0898561af3a9
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Macula_Densa_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	COL4A4 SGSM1 USP17L1 MECOM DAPK1 MGLL LRP1B	5.81e-06	181	168	7	22363c5835dd6cef8f895ab9362e0837d92b15b1
ToppCell	COVID-19-lung-AT1\|lung / Disease (COVID-19 only), tissue and cell type	COL4A4 OVCH2 MECOM MGLL SEMA3B CACNG4 FLRT3	6.25e-06	183	168	7	942530449e9c6583705eeb8f6f12621daea57252
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Macula_Densa_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	CPEB2 COL4A4 MECOM DAPK1 MGLL LRP1B CNTN1	6.47e-06	184	168	7	8fd8bd3d28d0ee6f0ef1f14e354d8eaf63a8081b
ToppCell	5'-GW_trimst-2-SmallIntestine-Hematopoietic-T_cells-Treg\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	IL10RA HLA-E HLA-F HLA-G TRBV7-3 TRBV7-2 SLA2	6.95e-06	186	168	7	2a9daf96c2a47f1ed5421130f32f17bd33e644a7
ToppCell	frontal_cortex-Neuronal-GABAergic_neuron-Sncg-Sncg_Vip_Nptx2\|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	LRAT HGFAC EPB41L4A STRIP2 ROBO1 CACNG4	7.00e-06	122	168	6	91e338db581b36baffecc323b1909f2069b27242
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	OVCH2 HDAC4 ADAMTS3 MECOM TMTC2 LRP1B TBC1D9	7.45e-06	188	168	7	4154f4787483c7e076e87a187733a9f666742c3d
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Macula_Densa_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	COL4A4 MECOM DAPK1 MGLL LRP1B CASD1 CNTN1	7.71e-06	189	168	7	e059be2965cca70ff5576df055d0af1775b76e00
ToppCell	3'_v3-lymph-node_spleen-Lymphocytic_T_CD4/8-lo-Tgd_CRTAM\|lymph-node_spleen / Manually curated celltypes from each tissue	HLA-E HLA-F TRGV2 TRGV3 TRGV4 TRGV5 EPB41L4A	7.71e-06	189	168	7	e8ff2c4fd2481bfbc99a5a6f02e0db8c995b3a23
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	CPEB2 CLDN14 MECOM DAPK1 MGLL LRP1B HIVEP3	7.98e-06	190	168	7	bf4511395fa97efd1c1cd17cc9bebb0271ee7f0e
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	CPEB2 CLDN14 MECOM DAPK1 MGLL LRP1B HIVEP3	7.98e-06	190	168	7	b6b8964b4910083499681b5fdf554e127b6a4c4e
ToppCell	RV-10._Endothelium_II\|RV / Chamber and Cluster_Paper	HLA-E MECOM DAPK1 EPB41L4A ADGRF5 CALCRL SMAD9	8.84e-06	193	168	7	01c2df9206f1527c578e808978e58196c35e72f5
ToppCell	TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6\|TCGA-Prostate / Sample_Type by Project: Shred V9	EPRS1 SMARCA5 G2E3 USP8 FAM120A KDM1B MED13	8.84e-06	193	168	7	abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659
ToppCell	10x_3'_v3-thymus_(10x_3'_v3)-lymphocytic-T_lymphocytic-CD8-positive,_alpha-beta_cytotoxic_T_cell\|thymus_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	IL10RA TRGV2 TRGV3 TRGV4 IRF1 PTGER2 SLA2	9.46e-06	195	168	7	730c613cf6f4d16ca51fd44de1f5a883f615c5c5
ToppCell	10x5'-bone_marrow-Lymphocytic_T_CD8\|bone_marrow / Manually curated celltypes from each tissue	HLA-E HLA-F TRGV2 TRGV3 IRF1 TRBV14 SLA2	9.78e-06	196	168	7	5c9ed3c6e3cbd43b52f0291b5c26dd7f9fadf3da
ToppCell	10x5'-blood-Lymphocytic_T_CD8-Tem/emra_CD8\|blood / Manually curated celltypes from each tissue	HLA-E HLA-F TRGV2 TRGV3 TRGV4 IRF1 SLA2	1.01e-05	197	168	7	13e6611cde9364f0c1bf681b0b26c4d2725e5f4a
ToppCell	LV-09._Endothelium_I\|LV / Chamber and Cluster_Paper	HLA-E MECOM TMTC2 MGLL EPB41L4A ADGRF5 CALCRL	1.01e-05	197	168	7	f9731d4d636e51b94a96805eee6afe9aedc175e3
ToppCell	TCGA-Skin-Metastatic-Melanoma\|TCGA-Skin / Sample_Type by Project: Shred V9	SMARCA5 ARID4B MECOM PTGER2 TBC1D9 ADGRF5 CALCRL	1.04e-05	198	168	7	af4fb9eb2295c7b90624b38ba25619aa15254efa
ToppCell	TCGA-Skin-Metastatic\|TCGA-Skin / Sample_Type by Project: Shred V9	SMARCA5 ARID4B MECOM PTGER2 TBC1D9 ADGRF5 CALCRL	1.04e-05	198	168	7	ad39cce004867f083f8da1954e0cf5a263815184
ToppCell	TCGA-Skin-Metastatic-Melanoma-Skin_Cutaneous_Melanoma\|TCGA-Skin / Sample_Type by Project: Shred V9	SMARCA5 ARID4B MECOM PTGER2 TBC1D9 ADGRF5 CALCRL	1.04e-05	198	168	7	62cbf4b29e8af4983fb47a17f96da62682a5137e
ToppCell	Bronchial-NucSeq-Epithelial-Epi_alveolar\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	COL4A4 GANC MECOM DAPK1 TMTC2 MGLL ADGRF5	1.08e-05	199	168	7	725610310e5c5fd7120c0be9acb55bf152026ddd
ToppCell	Bronchial-10x5prime-Immune_Lymphocytic-T-T_CD3\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	TRGV2 TRGV3 TRGV4 TRGV5 TRBV7-7 TRBV7-2 SLA2	1.08e-05	199	168	7	eb30711ab34510429b644498ecfab4ec3cb61cbc
ToppCell	Lung_Parenchyma-Severe-Epithelial-Epithelial-AT1-\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	COL4A4 HLA-G R3HDML ABCA7 SEMA3B ADGRF5 FXYD3	1.08e-05	199	168	7	f8846446ebbc4948cdc69640782db1358bbdc486
ToppCell	Biopsy_IPF-Epithelial-Transitional_AT2\|Biopsy_IPF / Sample group, Lineage and Cell type	COL4A4 MGLL ABCA7 SEMA3B ADGRF5 FLRT3 FXYD3	1.08e-05	199	168	7	83ff8b7e472d1212324c05cc719b746d19e5e23b
ToppCell	Transverse-T_cell-gd_T\|Transverse / Region, Cell class and subclass	TRGV2 TRGV3 TRGV4 TRGV5 TRBV7-7 SLA2 NCR2	1.08e-05	199	168	7	92554fddd887fe6c1c943ed704d4a02c999ba830
ToppCell	Transverse-(1)_T_cell-(17)_gd_T\|Transverse / shred on region, Cell_type, and subtype	TRGV2 TRGV3 TRGV4 TRGV5 TRBV7-7 SLA2 NCR2	1.08e-05	199	168	7	a3a29ed65881f1dcf09b2fec8788161ea3adef48
ToppCell	Parenchyma_COVID-19-Epithelial-TX-AT1\|Parenchyma_COVID-19 / Sample group, Lineage and Cell type	COL4A4 HLA-G R3HDML ABCA7 SEMA3B ADGRF5 FXYD3	1.08e-05	199	168	7	fe9f5bc317be0c35bd96311bf0b3c7b91d98acc5
ToppCell	Tracheal-10x5prime-Immune_Lymphocytic-T-T_CD8-CD8\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	IL10RA TRGV2 TRGV3 PTGER2 TRBV14 TRBV7-2 SLA2	1.08e-05	199	168	7	c3aa72555fa3c2a0d85172682972d91fd9bb7b6a
ToppCell	Bronchial-10x5prime-Immune_Lymphocytic-T-T_CD3-NKT\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	TRGV2 TRGV3 TRGV4 TRGV5 TRBV7-7 TRBV7-2 SLA2	1.08e-05	199	168	7	40f9f771004850be477ee491a7a74c74b84074ab
ToppCell	Lung_Parenchyma-Severe-Epithelial-Epithelial-AT1\|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09)	COL4A4 HLA-G R3HDML ABCA7 SEMA3B ADGRF5 FXYD3	1.08e-05	199	168	7	3e35ee426ef06f9af568c37349b62dd1ee9b97ea
ToppCell	distal-2-Epithelial-Alveolar_Epithelial_Type_1\|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	COL4A4 HLA-G MGLL SEMA3B FLRT3 FXYD3 IGSF3	1.11e-05	200	168	7	313ec1e53bd738a9cb48dc5b946261156f99f44b
ToppCell	Parenchymal-10x3prime_v2-Epithelial-Epi_alveolar-AT1\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	COL4A4 MGLL ABCA7 SEMA3B CACNG4 FLRT3 FXYD3	1.11e-05	200	168	7	3d51aebf626dd4656ab4aac8a20d761b8062c42d
ToppCell	Lung_Parenchyma-Control-Epithelial-Epithelial-AT1-\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	COL4A4 MGLL ABCA7 SEMA3B CACNG4 FLRT3 FXYD3	1.11e-05	200	168	7	c6f211bbadd0c9be776c58807249e06764df47dc
ToppCell	Lung_Parenchyma-Control-Epithelial-Epithelial-AT1\|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)	COL4A4 MGLL ABCA7 SEMA3B CACNG4 FLRT3 FXYD3	1.11e-05	200	168	7	5f7e8d8b05c90a10313775f9f126eb4ab0fe4f67
ToppCell	Parenchyma_Control_(B.)-Epithelial-TX-AT1\|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type	COL4A4 MGLL ABCA7 SEMA3B CACNG4 FLRT3 FXYD3	1.11e-05	200	168	7	e3a80626941363bfc9d97ef906d38c97080aecb1
ToppCell	Cerebellum-Endothelial-ENDOTHELIAL_STALK-Flt1_1-Endothelial_Stalk.Flt1.Car4_(Car4)\|Cerebellum / BrainAtlas - Mouse McCarroll V32	MSH5 PTGER2 TIGD3 SLC45A2 CNGB1	1.76e-05	85	168	5	bb9555652e93620d5aeeb71e915b3978a437407d
ToppCell	Cerebellum-Endothelial-ENDOTHELIAL_STALK-Flt1_1-Endothelial_Stalk.Flt1.Car4_(Car4)--\|Cerebellum / BrainAtlas - Mouse McCarroll V32	MSH5 PTGER2 TIGD3 SLC45A2 CNGB1	1.76e-05	85	168	5	f7935c3206310adafdecb75149c3b06c38e7780c
ToppCell	Cerebellum-Endothelial-ENDOTHELIAL_STALK-Flt1_1-Endothelial_Stalk.Flt1.Car4_(Car4)-\|Cerebellum / BrainAtlas - Mouse McCarroll V32	MSH5 PTGER2 TIGD3 SLC45A2 CNGB1	1.76e-05	85	168	5	43f6911b032718d8ba75fb7bba5f9b536a4b3260
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	HDAC4 ADAMTS3 TMTC2 LRP1B TBC1D9 ATG9A	2.54e-05	153	168	6	9b6675ace8a83c8d446b722301d0ec4e6840f3fc
ToppCell	PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Myeloid-Macrophage-macrophage,_alveolar-Macro_c2-CCL3L1\|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k)	DMXL2 LILRA1 OVCH2 DAPK1 TMTC2 ENO4	2.94e-05	157	168	6	a98d06cef80bfe8481b0940abce2b29675e45812
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	HDAC4 ADAMTS3 MECOM TMTC2 TBC1D9 ATG9A	2.94e-05	157	168	6	2c5295043611bac7dfa4aef2146681bce4a33a8f
ToppCell	PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Myeloid-Macrophage-macrophage,_alveolar\|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k)	DMXL2 LILRA1 MECOM DAPK1 TMTC2 ENO4	4.01e-05	166	168	6	28a44448a0b0d72459e8fe84ce5d666f16f514b3
ToppCell	PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Myeloid-Macrophage\|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k)	DMXL2 LILRA1 MECOM DAPK1 TMTC2 ENO4	4.01e-05	166	168	6	2a04915d534a83e65aa168435d6856125b5bdd78
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	ADGRB3 ADGRA2 RYR2 TMEM145 PKP1 ADGRF5	4.15e-05	167	168	6	e228b8373ffd4436e6b944e26d0fadf3ac289b21
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	ADGRB3 ADGRA2 RYR2 TMEM145 PKP1 ADGRF5	4.15e-05	167	168	6	7cb1b11e8e24a10115e46ffbb74889e672a7a026
ToppCell	5'-Adult-Appendix-Hematopoietic-Myeloid-Lymphoid_DC\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	DAPK1 GCGR ST3GAL6 VRTN ROBO1 CNGB1	4.15e-05	167	168	6	8b223333c0c7a85b5a1af6f2f5b12ee0d94357f6
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	ADGRB3 ADGRA2 RYR2 TMEM145 PKP1 ADGRF5	4.15e-05	167	168	6	bb53a478b5d821d6d82c15bc4ed075b67682457c
ToppCell	356C-Epithelial_cells-Epithelial-E_(AT2)-\|356C / Donor, Lineage, Cell class and subclass (all cells)	COL4A4 SEMA3B ADGRF5 FLRT3 FXYD3 IGSF3	4.58e-05	170	168	6	4cd3b7e43a061948084c01713ae141b5c2c07d89
ToppCell	356C-Epithelial_cells-Epithelial-E_(AT2)\|356C / Donor, Lineage, Cell class and subclass (all cells)	COL4A4 SEMA3B ADGRF5 FLRT3 FXYD3 IGSF3	4.58e-05	170	168	6	36c9f7f98612a72dc511c8da4358d67444f6bcf4
ToppCell	metastatic_Brain-T/NK_cells-Cytotoxic_CD8+_T\|metastatic_Brain / Location, Cell class and cell subclass	IL10RA HLA-E HLA-F ADGRB3 IRF1 TRBV14	4.74e-05	171	168	6	d3e1cc1b70256c4d01488d6b6130bbcae99bdeec
ToppCell	facs-Marrow-KLS-18m-Myeloid-promonocyte\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	IL10RA TMTC2 ADGRA2 TBC1D9 STRIP2 OCSTAMP	4.89e-05	172	168	6	979fd7b435f59b8a4d290a809cf76147d4c63d48
ToppCell	facs-Marrow-KLS-18m-Myeloid-monocyte_+_promonocyte\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	IL10RA TMTC2 ADGRA2 TBC1D9 STRIP2 OCSTAMP	4.89e-05	172	168	6	f4d7f416802218ce56408fa4cb8a555d846bc85b
ToppCell	facs-Large_Intestine-Distal-18m-Epithelial-Brush_cell_of_epithelium_proper_of_large_intestine\|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CLDN14 DMXL2 CHDH ADGRB3 CRHR1 STRIP2	5.39e-05	175	168	6	f24b664b9056b5976bf2222e8013f15c09e049ad
ToppCell	normal_Lymph_Node-Myeloid_cells-pDCs\|normal_Lymph_Node / Location, Cell class and cell subclass	LILRA1 CATSPERE SRD5A1 CASD1 NSUN3 LILRA4	5.56e-05	176	168	6	476794ef75ce5ab732d78cfeb4944e2f841e3e92
ToppCell	Brain_organoid-organoid_Kanton_Nature-Organoid-4M-Neuronal-ventral_progenitors_and_neurons_2\|Organoid-4M / Sample Type, Dataset, Time_group, and Cell type.	SMARCA5 DAPK1 TMTC2 STRIP2 ALDH9A1 LRRC17	6.11e-05	179	168	6	d95367d689732ab2653e8d70d8d8e5eb15ae6eef
ToppCell	COVID-19-Epithelial_cells-AT1\|COVID-19 / group, cell type (main and fine annotations)	COL4A4 OVCH2 MECOM SEMA3B ADGRF5 FLRT3	6.11e-05	179	168	6	a0b33bd69ffdfd5d38d80207fb40058a490aa19e
ToppCell	LPS_only-Myeloid-Monocytes,_Macrophages-Monocytes-Macrophages\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	IL10RA DMXL2 LILRA1 LILRA3 LILRA2 ST3GAL6	6.11e-05	179	168	6	dc03b9045510eb1bb934329646bb92dd06890ce9
ToppCell	5'-GW_trimst-2-LymphNode-Hematopoietic-T_cells-TRDV2/TRGV9_gdT\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	HLA-E TRGV2 TRGV3 TRGV4 TRGV5 SLA2	6.11e-05	179	168	6	f7d3d37505893ae55065c89d957084602729decc
ToppCell	LPS_only-Myeloid-Monocytes,_Macrophages\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	IL10RA DMXL2 LILRA1 LILRA3 LILRA2 ST3GAL6	6.11e-05	179	168	6	330c1326ba93bb8f32559ee1cc40e357cc44ad8d
ToppCell	Control-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	TMPRSS9 ADAMTS3 ECT2L RYR2 HIVEP3 LRRC17	6.30e-05	180	168	6	08ae0f5d95c45feba68ad99788f7af7ff4c979af
ToppCell	AT1_cells-Donor_08\|World / lung cells shred on cell class, cell subclass, sample id	COL4A4 ABCA7 SEMA3B ADGRF5 FLRT3 FXYD3	6.30e-05	180	168	6	2d52cb5f77dde0e3dccac1333d4ec67ec680fcb2
ToppCell	LPS-IL1RA-Myeloid-Monocytes,_Macrophages-Monocytes-Macrophages\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	IL10RA DMXL2 LILRA1 LILRA3 LILRA2 ST3GAL6	6.30e-05	180	168	6	97241f62ee133dcb0d4855ffda5dd1349de9f7b2
ToppCell	LPS-IL1RA-Myeloid-Monocytes,_Macrophages\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	IL10RA DMXL2 LILRA1 LILRA3 LILRA2 ST3GAL6	6.30e-05	180	168	6	41896546cd1cc458e08c0d4e19aa4860e5d4fcd6
ToppCell	Smart-seq2-spleen_(Smart-seq2)-lymphocytic-T_lymphocytic-type_I_NK_T_cell\|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	TRGV3 TRGV4 TRGV5 EPB41L4A PTGER2 SLA2	6.69e-05	182	168	6	9d727ab84da8de33f1021b492c90d8b4c2a8ea23
ToppCell	IPF-Epithelial-ATI\|IPF / Disease state, Lineage and Cell class	COL4A4 OVCH2 SEMA3B ADGRF5 FLRT3 FXYD3	6.90e-05	183	168	6	c0a3541c45bd0c587603521f392f42dd86c3c35b
ToppCell	nucseq-Epithelial-Epithelial_Alveolar-AT1-AT1\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	COL4A4 OVCH2 MECOM TMTC2 MGLL SEMA3B	7.11e-05	184	168	6	57c792e6e2fedba25d3350ffe649fd74750b579d
ToppCell	343B-Lymphocytic-CD4_T-cell-CD4+_Effector_T_cell-2\|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells)	DHX16 TBC1D9B MGLL EPB41L4A SLC4A2 CASD1	7.11e-05	184	168	6	2c2125b8030af83f7a6d59a7102d4de8e0ac1988
ToppCell	343B-Epithelial_cells-Epithelial-I_(AT1)\|343B / Donor, Lineage, Cell class and subclass (all cells)	COL4A4 TMTC2 ABCA7 SEMA3B CACNG4 FXYD3	7.11e-05	184	168	6	cb15d6bae52c5ec251c2235859dc7e65f630ae23
ToppCell	343B-Epithelial_cells-Epithelial-I_(AT1)-\|343B / Donor, Lineage, Cell class and subclass (all cells)	COL4A4 TMTC2 ABCA7 SEMA3B CACNG4 FXYD3	7.11e-05	184	168	6	bde4eaabd3e9bdaed23867d23a919b9d84b52d4b
ToppCell	nucseq-Epithelial-Epithelial_Alveolar-AT1\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	COL4A4 OVCH2 MECOM TMTC2 MGLL SEMA3B	7.11e-05	184	168	6	d7bd0f0c607bade67c99e9fb3578a570298bf926
ToppCell	Control-Epithelial-ATI\|World / Disease state, Lineage and Cell class	COL4A4 OVCH2 SEMA3B ADGRF5 FLRT3 FXYD3	7.33e-05	185	168	6	0563d5042bb96ecce8446fbf26d05ef7a45e23c5
ToppCell	LV-10._Endothelium_II\|World / Chamber and Cluster_Paper	HLA-E MECOM EPB41L4A ADGRF5 CALCRL SMAD9	7.77e-05	187	168	6	7876dcb4800c2e54874df3d933efb79307a64a97
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	CPEB2 MECOM DAPK1 MGLL LRP1B HIVEP3	7.77e-05	187	168	6	87b3d0478693d4c54ff06b74e5903036b9c1ee6a
ToppCell	primary_auditory_cortex_(A1C)-Non-neuronal-Endothelial_Myeloid-Endo-Endothelial\|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	HLA-E HLA-G MECOM IRF1 R3HDML ADGRF5	7.77e-05	187	168	6	698ae9eefa8ba97fea8ea61e4e868edd194de03b
ToppCell	Control-Epithelial-ATI\|Control / Disease state, Lineage and Cell class	COL4A4 OVCH2 SEMA3B ADGRF5 FLRT3 FXYD3	7.77e-05	187	168	6	fdd1c57b61ca9392ac27661a82729f37593df63c
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	CPEB2 MECOM DAPK1 MGLL LRP1B HIVEP3	7.77e-05	187	168	6	42a1267bfc27b4460b8409ada580a87c4385841c
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	CPEB2 MECOM DAPK1 MGLL LRP1B HIVEP3	7.77e-05	187	168	6	64afdea159f5e67a1e5cea35ce898aae6e80aea5
ToppCell	primary_auditory_cortex_(A1C)-Non-neuronal-Endothelial_Myeloid-Endo\|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	HLA-E HLA-G MECOM IRF1 R3HDML ADGRF5	7.77e-05	187	168	6	ed8816433d1086a634892502898255b487a2d4a7
ToppCell	primary_auditory_cortex_(A1C)-Non-neuronal-Endothelial_Myeloid-Endo-Endothelial-Endo_L2-5_CLDN5\|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	HLA-E HLA-G MECOM IRF1 R3HDML ADGRF5	7.77e-05	187	168	6	d8b09398400a178b03e641af1476c4dac0c6e82a
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	HDAC4 ADAMTS3 MECOM TMTC2 LRP1B TBC1D9	8.24e-05	189	168	6	90aae7e806882bebfad78a78e9a16cf56af3ecd4
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	CPEB2 CLDN14 MECOM DAPK1 MGLL LRP1B	8.73e-05	191	168	6	2fa1b9e76a0ed2d2f0de74349e266cf4a5f51aad
ToppCell	COVID-19-kidney-TAL\|COVID-19 / Disease (COVID-19 only), tissue and cell type	COL4A4 CLDN14 MECOM DAPK1 MGLL LRP1B	8.73e-05	191	168	6	fe55475ce0666ab5122447a813dc2369e24947b8
ToppCell	5'-Adult-LargeIntestine-Epithelial-Tuft-related-Tuft\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	SGSM1 GANC CHDH DAPK1 ANO7 IGSF3	8.73e-05	191	168	6	54f07e4de61735051498846afb44b1798bed8144
ToppCell	COVID-19-Heart-EC_(POSTN)\|Heart / Disease (COVID-19 only), tissue and cell type	HLA-E MECOM DAPK1 EPB41L4A CALCRL SMAD9	8.99e-05	192	168	6	c0c34785a7bdf461722029b322e9184e3d9b3c26
ToppCell	COVID-19-kidney-CNT\|kidney / Disease (COVID-19 only), tissue and cell type	COL4A4 ADAMTS3 MECOM TMTC2 LRP1B TBC1D9	8.99e-05	192	168	6	d32ae226d95b4b6adb99d14b602be09b661d4cd9
ToppCell	human_hepatoblastoma-Endothelial_cells\|human_hepatoblastoma / Sample and Cell Type and Tumor Cluster (all cells)	MGLL EPB41L4A HIVEP3 ADGRF5 CALCRL FAR1	8.99e-05	192	168	6	e09f609fed033a25baacaf4a07bbbae1076da366
ToppCell	Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D062\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	COL4A4 OVCH2 MECOM DAPK1 ADGRF5 FLRT3	8.99e-05	192	168	6	29f49f00770c991b5f27e4cb701dd2d2d6cb7178
ToppCell	AT1_cells-Donor_02\|World / lung cells shred on cell class, cell subclass, sample id	COL4A4 OVCH2 ABCA7 SEMA3B CACNG4 FXYD3	8.99e-05	192	168	6	0444f9e9cef7403e220e862b5a787443d3f5c9ac
ToppCell	5'-Adult-SmallIntestine-Hematopoietic-T_cells-TRGV2_gdT\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	IL10RA TRGV2 PTGER2 TRBV7-4 SLA2 NCR2	9.25e-05	193	168	6	544de0988510cc57744710d7cafe07aa27a0b99d
ToppCell	wk_20-22-Hematologic_Lymphocytic-T_&_ILC-Th17\|wk_20-22 / Celltypes from embryonic and fetal-stage human lung	HLA-E TRGV2 TRGV3 TRGV4 TRGV5 PTGER2	9.25e-05	193	168	6	4112eed9327e1d5a7e829fce6b2437287e14464e
ToppCell	wk_15-18-Hematologic_Lymphocytic-T_&_ILC-NKT1\|wk_15-18 / Celltypes from embryonic and fetal-stage human lung	HLA-E HLA-F TRGV2 TRGV3 TRGV4 SLA2	9.25e-05	193	168	6	52f42ec293a5077a44de5c27e89b57c23944e560
ToppCell	5'-Adult-LargeIntestine-Hematopoietic-T_cells-CD8_Tmem\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	IL10RA HLA-E HLA-F TRGV2 PTGER2 SLA2	9.51e-05	194	168	6	9344556b375fd9267652cdca57b2cbd50a878a1e
ToppCell	healthy_donor-Myeloid-Monocytic-CD16+_Monocyte\|healthy_donor / Disease condition, Lineage, Cell class and subclass	DMXL2 LILRA1 LILRA3 LILRA2 DAPK1 KDM1B	9.51e-05	194	168	6	ecf746ef1c5c4d6d9ca06a6d3e3778670b5700c2
ToppCell	COVID_vent-Myeloid-Monocytic-CD16+_Monocyte\|COVID_vent / Disease condition, Lineage, Cell class and subclass	LILRA1 LILRA3 LILRA2 DAPK1 MGLL KDM1B	9.51e-05	194	168	6	b133d3d198360269cc449a75d34c29be377d91e0
ToppCell	LV-10._Endothelium_II\|LV / Chamber and Cluster_Paper	HLA-E MECOM EPB41L4A ADGRF5 CALCRL SMAD9	9.51e-05	194	168	6	b6cc849fa08599bff9839ef382d190cc964e273e
Computational	Neighborhood of CD97	IL10RA HLA-E HLA-F HLA-G PTGER2	1.19e-05	38	86	5	GNF2_CD97
Computational	Genes in the cancer module 293.	HLA-E HLA-F HLA-G	1.03e-04	12	86	3	MODULE_293
Computational	Genes in the cancer module 143.	HLA-E HLA-F HLA-G	1.69e-04	14	86	3	MODULE_143
Computational	Neighborhood of ICAM3	HLA-E HLA-F HLA-G IRF1	2.54e-04	39	86	4	GNF2_ICAM3
Computational	Neighborhood of HLA-C	HLA-E HLA-F HLA-G IRF1	5.24e-04	47	86	4	GNF2_HLA_C
Disease	primary ovarian insufficiency (implicated_via_orthology)	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 MSH5 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	4.77e-36	46	161	21	DOID:5426 (implicated_via_orthology)
Disease	congenital heart disease (implicated_via_orthology)	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 HCFC2 USP17L22 USP17L15 USP17L8 USP17L13 NAA16	1.74e-33	69	161	22	DOID:1682 (implicated_via_orthology)
Disease	graft-versus-host disease (implicated_via_orthology)	HLA-E HLA-F HLA-G	5.49e-06	7	161	3	DOID:0081267 (implicated_via_orthology)
Disease	nephrotic syndrome type 20 (implicated_via_orthology)	TBC1D9B TBC1D9	1.76e-04	4	161	2	DOID:0070357 (implicated_via_orthology)
Disease	Pulmonary Hypertension, Primary, 1, With Hereditary Hemorrhagic Telangiectasia	HDAC4 SMAD9	6.10e-04	7	161	2	C3714844
Disease	Pulmonary Hypertension, Primary, 1	HDAC4 SMAD9	6.10e-04	7	161	2	C4552070
Disease	PULMONARY HYPERTENSION, PRIMARY, DEXFENFLURAMINE-ASSOCIATED	HDAC4 SMAD9	6.10e-04	7	161	2	C1969342
Disease	Pulmonary Hypertension, Primary, Fenfluramine-Associated	HDAC4 SMAD9	6.10e-04	7	161	2	C1969343
Disease	Autistic behavior	ZNF462 MED13	8.11e-04	8	161	2	C0856975
Disease	triacylglycerol 58:6 measurement	LRP1B HIVEP3	8.11e-04	8	161	2	EFO_0010440
Disease	eye color	CLDN14 TTC3 HIVEP3 SLC45A2	1.52e-03	90	161	4	EFO_0003949
Disease	Myeloproliferative disease	MPL MECOM	1.88e-03	12	161	2	C0027022
Disease	folic acid measurement	IL10RA PHF1 MYO15A	2.04e-03	46	161	3	EFO_0005111
Disease	juvenile polyposis syndrome (implicated_via_orthology)	HIVEP3 SMAD9	2.22e-03	13	161	2	DOID:0050787 (implicated_via_orthology)
Disease	leukocyte immunoglobulin-like receptor subfamily B member 1 measurement	LILRA1 LILRA2	2.97e-03	15	161	2	EFO_0008208
Disease	fibrinogen measurement	LRAT HGFAC LHFPL4 IRF1	3.05e-03	109	161	4	EFO_0004623
Disease	phosphatidylcholine 38:6 measurement	AHCTF1 DEPDC5	3.38e-03	16	161	2	EFO_0010388
Disease	Idiopathic pulmonary arterial hypertension	HDAC4 SMAD9	3.38e-03	16	161	2	C3203102
Disease	Familial primary pulmonary hypertension	HDAC4 SMAD9	3.81e-03	17	161	2	C0340543
Disease	nevus count	HDAC4 SLC45A2	4.27e-03	18	161	2	EFO_0004632
Disease	skin sensitivity to sun	ANKRD11 SLC45A2	4.76e-03	19	161	2	EFO_0004795
Disease	Phenyllactate (PLA) measurement	IPO8 DAPK1	4.76e-03	19	161	2	EFO_0021662
Disease	Deaf Mutism	CLDN14 TMTC2	5.27e-03	20	161	2	C4082305
Disease	Deafness, Acquired	CLDN14 TMTC2	5.27e-03	20	161	2	C0751068
Disease	Hearing Loss, Extreme	CLDN14 TMTC2	5.27e-03	20	161	2	C0086395
Disease	Complete Hearing Loss	CLDN14 TMTC2	5.27e-03	20	161	2	C0581883
Disease	Bilateral Deafness	CLDN14 TMTC2	5.27e-03	20	161	2	C3665473
Disease	Prelingual Deafness	CLDN14 TMTC2	5.27e-03	20	161	2	C0011052

Protein segments in the cluster

Peptide	Gene	Start	Entry
DECLSYLFGWIHYRR	PRAMEF33	161	A0A0G2JMD5
EVLYLVHYCGWNVRY	ARID4B	601	Q4LE39
AWHGYYSVAKALCEA	DAPK1	486	P53355
FCSSNHLEYLVGRVW	SLC4A2	781	P04920
CLSGYQWNTSICLHY	ADGRF3	181	Q8IZF5
DISWQCLEYYAGLAA	ALDH9A1	111	P49189
CSGHTLLEYVQVYWL	AQP12A	211	Q8IXF9
GWTALHEACNRGYYD	ANKRD11	201	Q6UB99
RYLFVESSHTCFLWY	CATSPERE	91	Q5SY80
NIHNYRDHSPYCWLV	ADGRA2	906	Q96PE1
FTRTKGYGTDHYCWL	ADGRB3	1001	O60242
HYCWLSLEGGLLYAF	ADGRB3	1011	O60242
RVDLKEYVGYCSHWQ	BCS1L	346	Q9Y276
ALVCWYVHRNGSLFS	FLRT3	546	Q9NZU0
CHYAQRNDRSYWLAS	COL4A4	1531	P53420
IYSLHVLEGCWVLYE	CRYGA	121	P11844
NEYGAWKRHYIACVS	ECT2L	136	Q008S8
TLRTQCGHLYAYDWI	BEST1	216	O76090
SLLACQSYIWIGEEY	DMXL2	2691	Q8TDJ6
CSGHTLLEYVQVYWL	AQP12B	211	A6NM10
AGKCFRLYTAWAYQH	DHX16	731	O60231
AALYGLATWYLEAVC	ABCA7	741	Q8IZY2
DRYNWCYHTEVQRGL	CHDH	101	Q8NE62
VVHCARKTEYALWNY	RIC1	901	Q4ADV7
DACLFRSWAIHTGRY	IRF1	51	P10914
SDHEATLRCWALGFY	HLA-F	216	P30511
GQYRCYSAHNLSSEW	LILRA2	291	Q8N149
SWLKYIRFAGCYDQH	MECOM	146	Q03112
LLSASWAVLCYYAED	ANO7	171	Q6IWH7
RAYLEGTCVEWLHRY	HLA-G	181	P17693
NNRTDRLEWCSCYYH	DEPDC5	1361	O75140
GYLHCNEYDSLRLRW	NSUN3	156	Q9H649
SDHEATLRCWALGFY	HLA-E	216	P13747
GQYRCYGAHNVSSEW	LILRA4	291	P59901
RQLHWAEYIENYCLG	FAR1	426	Q8WVX9
LNHCISSDPRYWYGK	HDAC4	191	P56524
AGHCAVAIGTRLYFW	HCFC2	316	Q9Y5Z7
TLDFHTNTLYWCDAY	LRP1B	701	Q9NZR2
HYWCRIYRPSDNSVS	NCR2	106	O95944
LWTLVSFRYHCQLYS	MARCHF2	191	Q9P0N8
SFRYHCQLYSEWRKT	MARCHF2	196	Q9P0N8
HLVNADGQYLFCRYW	MGLL	21	Q99685
QLRHYCEPYTTWCQE	APOO	66	Q9BUR5
WRLLYIVTAYHSCSE	MYO15A	3136	Q9UKN7
SYLRLYDNPWHCTCE	LRRC17	156	Q8N6Y2
LYSGCQDSLRVYGWE	KATNB1	246	Q9BVA0
RHGYIWDRHYNICLA	FBXW5	491	Q969U6
DWYQFVLRQLECYHS	PCNX4	936	Q63HM2
WCFIRHGRTAYLQLY	PTGER2	186	P43116
TQRASWIGYAIAYHL	NAA16	146	Q6N069
SSWSDYIHICNIYGE	DCAF11	236	Q8TEB1
FSLGYHQCRWNYEDE	GANC	361	Q8TET4
VANYCWLLVEGLYLH	GCGR	236	P47871
GSLSWRVYHHYIQAA	ABCC11	786	Q96J66
TGWQRYDHYSVLCEL	HEXD	296	Q8WVB3
LLWNNCEHFVTYCRY	LRAT	156	O95237
HYACWYGKVEATRIL	KRIT1	326	O00522
CYEVALLRYGIESWN	IL10RA	56	Q13651
SDRDTYLWIGYLCAI	ABCC2	351	Q92887
DNCLHRLYGGFYTDW	FAM120A	51	Q9NZB2
THNYDRDRAWGYCVE	HGFAC	136	Q04756
YSLGDCSVRWAYILA	LHFPL4	166	Q7Z7J7
YYLLHETWRFGAAAC	OXER1	151	Q8TDS5
AILCAEGHPRYTWYN	OTOP1	411	Q7RTM1
KLVYYTGCTWRSRHL	FRMD1	306	Q8N878
WNLTVHYYCLLMSSG	G2E3	36	Q7L622
YHWSRCSGQELKRYI	ADAMTS3	436	O15072
DSGSYYCHVEEWLLS	IGSF3	776	O75054
LWIGYCAFHLGDYKR	TTC26	61	A0AVF1
YLREEHLYCIWCGTA	GPATCH11	251	Q8N954
ERCAKNGYTSRWYHL	KDM1B	71	Q8NB78
FICQYHIWLAADTRG	CASD1	711	Q96PB1
QYYCEFCWANIHSRA	CPEB2	551	Q7Z5Q1
DYWLYSSAHICNGTN	CACNG4	31	Q9UBN1
WHSTGIYQCQIYRSL	CLDN14	56	O95500
APALSHYALCRYAEW	GBA2	441	Q9HCG7
CWSLYGRCYLRHFNE	ATG9A	331	Q7Z3C6
TTCLAEFTWYRRYGH	CNTN1	16	Q12860
LAHVLAWTYAFYDNC	CYP4F2	31	P78329
WCRLVTAAYNYFHVT	CRHR1	216	P34998
QWDSIYHALGSRCYI	ENO4	451	A6NNW6
YLHNCSYFALWSLES	AHCTF1	421	Q8WYP5
REWATYTCVLGFHVY	EML3	771	Q32P44
YCDRSHQTYWLDPAK	EPB41L4A	61	Q9HCS5
HYRYLCISHLIGWTA	SLC45A2	316	Q9UMX9
CYIQHVDTGLWLTYQ	RYR2	361	Q92736
WIVAAYAHFAVCYRI	KCTD3	196	Q9Y597
LYYNDNCWISSDTHL	CALCRL	276	Q16602
TWHRAAYLVCNYAIK	R3HDML	196	Q9H3Y0
LSITWEHAGRYCCIY	LILRA3	86	Q8N6C8
QALYARGYCWTELRD	PANX2	91	Q96RD6
SCWSRDQNHLPYIDY	JARID2	926	Q92833
GYLRARSCWVLHAFS	IPO8	471	O15397
HLCVLWNSGYLGIAY	MSH5	51	O43196
WDAGHLSNRQQSYCY	PHF1	176	O43189
GWLYHSDAIRTYLNL	PKP1	541	Q13835
YYDWHSLQVGGLICA	FXYD3	31	Q14802
AAAALDYRCPVHFYW	MRPS30	196	Q9NP92
YLECSAKYNWHVLRL	RASL10A	156	Q92737
RAIWNYIHCVFGIRY	SESN2	391	P58004
VWIRCTHSENYYSSD	DROSHA	411	Q9NRR4
HDISGCYILRPWAYA	EPRS1	1041	P07814
RVVCASYEDYGHWLL	PLEKHN1	296	Q494U1
SYEDYGHWLLCLRAV	PLEKHN1	301	Q494U1
CDLAEGSNGYIHWYL	TRGV2	41	A0A075B6R0
RHYRIHCLDNGWLYI	SLA2	146	Q9H6Q3
VDVLHWSRYNCFLLY	STRIP2	146	Q9ULQ0
LTLWKEQNYCESRYH	GET4	151	Q7L5D6
RCYAYDSNSPHVWSL	LILRA1	196	O75019
LHLYYESKQRCVWTL	OVCH2	331	Q7RTZ1
LCISLYRYWRHSPNV	PNLDC1	481	Q8NA58
SAVFLYYVLHCILWG	ST3GAL6	11	Q9Y274
YMSAVCWLFGRHLYD	SIAE	191	Q9HAT2
CDLTVTNTFYIHWYL	TRGV3	41	P03979
CDLTVINAFYIHWYL	TRGV5	41	A0A0B4J1U4
GLLVESAWYLHCYLT	OCSTAMP	236	Q9BR26
SAWYLHCYLTDLRFD	OCSTAMP	241	Q9BR26
FVGYCLSHDQRWILA	MED13	1791	Q9UHV7
WLVNQHRDSYCSYMG	SF3B5	31	Q9BWJ5
QHWCSVAYYELNNRV	SMAD9	271	O15198
RQGWLYLTVNHLCFY	TBC1D9B	171	Q66K14
TREWNGTYHCIFRYK	ADGRF5	536	Q8IZF2
LWRIHQALYCFDYDL	NCAPG2	186	Q86XI2
LSWYDAQQHCRLHYT	CLEC20A	31	Q6ZU45
HWNSCLYFALSRYLG	CNGA4	181	Q8IV77
THWVYDGVGNSYIRC	CNGB1	821	Q14028
LFILHINACVYYWAS	CNGB3	361	Q9NQW8
YLGIYRANRWHLCPT	C11orf68	251	Q9H3H3
YSGIDEALLCWYHIA	TIGD3	76	Q6B0B8
VYVLYAVLVHAGWSC	USP17L3	316	A6NCW0
VYVLYAVLVHAGWSC	USP17L4	316	A6NCW7
WHGLQTFSLERTCCY	SEMA3B	41	Q13214
CDWRNLHTVAFYTGL	TMTC2	306	Q8N394
RCDPISGHTALYWYR	TRBV7-3	41	A0A075B6L6
SGHTALYWYRQSLGQ	TRBV7-3	46	A0A075B6L6
YALFKAEHLTSCYWG	TBC1D9	831	Q6ZT07
VYVLYAVLVHAGWSC	USP17L18	316	D6R9N7
RWQITGECLEVYYGH	PLAA	216	Q9Y263
DRRSSVYAGWCISLY	HIVEP3	1621	Q5T1R4
VHDGRSWYILGNSYL	TTC5	176	Q8N0Z6
VYVLYAVLVHAGWSC	USP17L5	316	A8MUK1
HWVRALVAAQSYLYS	TRAF7	521	Q6Q0C0
VYVLYAVLVHAGWSC	USP17L21	316	D6R901
RWLLSAAHCFDVYGD	TMPRSS9	861	Q7Z410
NTWPKGHYRYCDALS	TTC3	296	P53804
VYVLYAVLVHAGWSC	USP17L13	316	C9JLJ4
DECLSYLFGWIHYRR	PRAMEF10	161	O60809
CDLAEGSTGYIHWYL	TRGV4	41	A0A0C4DH28
VYVLYAVLVHAGWSC	USP17L19	316	D6RCP7
RCDPISSHATLYWYQ	TRBV7-7	41	A0A0K0K1E9
QEYKVWCLGNETRYH	ROBO1	811	Q9Y6N7
VYVLYAVLVHAGWSC	USP17L1	316	Q7RTZ2
ILSRAFYGWLAYCRH	SGSM1	546	Q2NKQ1
FYGWLAYCRHLSTVR	SGSM1	551	Q2NKQ1
CSYIWQHIEIGYVQG	SGSM1	966	Q2NKQ1
TCYQLRYTGEGHQDW	MPL	421	P40238
AWEPHRNYVTRYCQG	SMUG1	61	Q53HV7
VYVLYAVLVHAGWSC	USP17L12	316	C9JPN9
VYVLYAVLVHAGWSC	USP17L24	316	Q0WX57
GLIEAGYHCEWCIYS	ZNF462	1306	Q96JM2
IFGAYWRSQIKYLHC	USP17L7	196	P0C7H9
VYVLYAVLVHAGWSC	USP17L7	316	P0C7H9
VYVLYAVLVHAGWSC	USP17L8	316	P0C7I0
QSRYLSHCAVYADDW	SRD5A1	131	P18405
VYVLYAVLVHAGWSC	USP17L6P	316	Q6QN14
YSHWLAQYCSEVHRQ	XPO6	631	Q96QU8
RCDPISGHTALYWYR	TRBV7-2	41	A0A1B0GXF2
SGHTALYWYRQSLGQ	TRBV7-2	46	A0A1B0GXF2
WRNYEYCRLDGQTPH	SMARCA5	521	O60264
TYYAWKHELLGSGTC	VRTN	346	Q9H8Y1
VYVLYAVLVHAGWSC	USP17L22	316	D6RA61
VYVLYAVLVHAGWSC	USP17L15	316	C9J2P7
VYVLYAVLVHAGWSC	USP17L17	316	D6RBQ6
CAMSWRAHYGEVYSV	WDR91	596	A4D1P6
RCDPISGHDNLYWYR	TRBV14	41	A0A5B0
RAQYYHSCGRESVIW	THEGL	241	P0DJG4
GHYTAYCKNAARQRW	USP8	1066	P40818
GIYYWNSRCVFHKRN	ZNF214	226	Q9UL59
VYVLYAVLVHAGWSC	USP17L2	316	Q6R6M4
HYLTVNLTTLRVWCY	USP33	101	Q8TEY7
RCDSISGHVTLYWYR	TRBV7-4	41	A0A1B0GX95
VYVLYAVLVHAGWSC	USP17L20	316	D6RJB6
AYVWFCYAVLVSLRH	TMEM145	326	Q8NBT3
VYVLYAVLVHAGWSC	USP17L10	316	C9JJH3
GRWTDYAKRYCNAHI	ZRANB3	211	Q5FWF4
VYVLYAVLVHAGWSC	USP17L11	316	C9JVI0